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Abstract 
Mechanical factors have been shown to significantly influence stem cell 
differentiation and fate. Researchers have demonstrated that nanoscale vibration 
can promote osteogenesis in isolated mesenchymal stem cell (MSC) cultures. In 
the bone marrow niche, there is a co-dependent existence between MSCs and cells 
from the haematopoietic lineage (HSCs), particularly osteoclasts. While MSC 
derived osteoblasts stimulate new bone formation, osteoclasts resorb bone. Given 
the close overlap between these two cells types, an investigation in to the effect 
of nanoscale vibration on osteoclasts was required.  
Two culture methods were used: an isolated culture of osteoclasts and osteoclast-
precursors, and a co-culture of bone marrow stromal cells and bone marrow 
haematopoietic cells. Vibration was produced with the Nanokick bioreactor – a 
recently developed technology that facilitates the delivery of accurate and 
reproducible nanoscale vertical displacements. This bioreactor allows otherwise 
standard cell culture techniques to be used. A range of experiments was used to 
investigate the effect of nanoscale vibration, including immunostaining, 
resorption analysis, RT-qPCR, ELISA and metabolomics.  
Nanoscale vibration was found to influence osteoclast differentiation and 
function. A reduction in osteoclast numbers was observed in both culture 
conditions. Furthermore, less resorption occurred in the nanokick group. There 
was no significant impairment in osteoblast development or function when 
osteoclasts were present, with evidence of increased cytoskeleton tension and 
mineralisation following stimulation. A number of changes in gene, protein and 
regulations were observed, suggesting a state of lower inflammation in the 
nanokick group.  
It is hoped that these results will provide further evidence to validate the use of 
the nanokick bioreactor as a method of producing tissue-engineered bone graft 
for clinical applications.   
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 Introduction  
1.1 Bone 
Bone is a complex tissue that is constantly changing in response to structural and 
hormonal signals. It plays a crucial role in multiple functions, including 
haematopoiesis, mineral homeostasis and locomotion through the attachment of 
muscles. The chemical and biological composition of bone renders it ideal for 
these roles. Regarding composition, it can be split into a cellular and acellular 
component, the latter of which is further divided into organic and inorganic 
elements. By weight, the inorganic component composes around 65%, compared 
to 20% organic and the remainder being water (Xu Feng, 2009). The inorganic 
matrix is primarily crystalline hydroxyapatite, which provided the compressive 
strength of bone, and osteocalcium phosphate (brushite). This matrix serves as a 
reservoir for 99% of the body’s calcium, 85% phosphorus and 50% of total sodium 
and potassium. The organic component comprises over 30 proteins with type 1 
collagen representing >90% of these. Type 1 collagen provides tensile strength 
while proteoglycans, matrix proteins and growth factors influence mineralisation 
and cell function. The cellular component is comprised of osteoblasts, osteoclasts 
and osteocytes. Osteocytes represent 90 - 95% of total cell numbers and help 
orchestrate skeletal metabolism (Schaffler MB et al, 2014). Osteoblasts, derived 
from mesenchymal stromal cells (MSC), and osteoclasts, formed from 
haematopoietic stem cells (HSC), are responsible for the formation and resorption 
of bone, respectively (Xu Feng, 2009). The structure of cortical bone is presented 
in Figure 1:1. Macroscopically, bone is comprised of compact and trabecular 
components. Although they are composed from the same matrix components, 
their density is significantly different. Compact bone is denser and as such has a 
greater compressive strength. Trabecular bone, conversely, is made up of a 
network of interconnected trabeculae, leading to a greater surface area. 
Trabecular bone is also more metabolically active, acting as a reservoir of calcium 
that is important in maintaining homeostasis (Buckwalter JA et al, 1996). 
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Figure 1:1 Structure of cortical bone. 
A – black and white micrography image (scale bar in µm) showing osteocytes (white dots) linked by 
processes (fine white lines). B – schematic representation of bone in cross section, highlighting 
compact and trabecular bone. Note the lacuna and canaliculi surrounding the osteocyte processes. 
These fluid filled spaces help facilitate the detection of hydrostatic pressure change in response to 
mechanical stimulation by osteocytes. Figure used with permission from the Springer Nature (Taylor 
D et al, 2007). 
1.2 Mesenchymal stem cells 
Mesenchymal stem cells are present within bone marrow as undifferentiated cells 
that have the potential to progress down a range of tissue lineages, including 
muscle (myocytes), fat (adipocytes) and bone (osteoblasts). They are therefore 
crucial for tissue regeneration following trauma, age or disease (Pittenger MF et 
al, 1999). These characteristics have led to detailed investigations by the 
scientific community into their potential uses in novel cellular therapies. They are 
defined by three criteria: 1) adherence to plastic, 2) specific surface antigen 
expression (namely CD105, CD73 and CD90, and lack CD45, CD34, CD14, CD11b, 
CD79a, CD19 and HLA-DR), and 3) multipotent differentiation (Dominici M et al, 
2006). There is no sole marker that is truly MSC-specific (Lv FJ et al, 2014). The 
route of differentiation can be influenced by a number of chemical, biological and 
physical factors within the cells’ microenvironment (Robertson SN et al, 2018). 
The exploration of physical factors and mechanical properties has prompted a 
range of new materials tools to be developed, including nanotopography 
(McMurray RJ et al, 2011) and hydrogels (Engler AJ et al, 2006). These materials 
are believed to effect change by altering MSC cytoskeleton dynamics and 
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intracellular tension (Kilian KA et al, 2010b). More recently, evidence has emerged 
that mechanotransduction, whereby cells are vibrated at specific frequencies and 
amplitudes, may play an important role in determining cell fate (Xiao G et al, 
2002, Nikukar H et al, 2013, Nikukar H et al, 2016).  
1.3 Osteoblasts 
Osteoblasts are derived from MSCs through a multi-step differentiation pathway 
(Neve A et al, 2011). They are mononucleated, measuring around 25 μm in 
diameter. Their most obvious role is the production of new bone through the 
secretion of type 1 collagen, which forms the majority of the organic matrix. The 
collagen molecules arrange in a triple helix to form fibrils, which then produce 
concentric weaves (Viguet-Carrin S et al, 2006). This configuration improves the 
strength of bone.  
Osteoblasts also closely interact with osteoclasts, which cannot mature and 
therefore resorb bone without their presence (Young PS et al, 2015). As such, they 
have a large influence on the overall process of bone remodelling. Osteoblast 
differentiation and growth is influenced by a number of factors, including bone 
morphogenic proteins (BMP), insulin-like growth factor (IGF) and mechanical 
forces (Neve A et al, 2011). As the cells progress in to the mineralisation phase, 
they produce proteins including osteopontin (OPN) and osteocalcin (OCN) (Neve A 
et al, 2011). OPN expression is regulated by mechanical stress and influences bone 
homeostasis (Fujihara S et al, 2006). OCN regulates mineral deposition and 
promotes osteoblast differentiation and activation (Chenu C et al, 1994). Both 
OPN and OCN can be used as a marker of mature osteoblasts (Lian JB et al, 1991, 
Neve A et al, 2011).   
1.4 Osteocytes 
Osteocytes are the most abundant cell type in bone, making up 90 – 95% of total 
cell numbers (Schaffler MB et al, 2014). They are formed from osteoblasts that 
have become enclosed in unmineralised matrix. Structurally, they are dendritic in 
appearance with long cellular processes that communicate with nearby osteocytes 
and osteoblasts (Schaffler MB et al, 2014). These processes are elongated through 
the production of E11/gp38 proteins in response to mechanical stresses (Zhang K 
Chapter 1 Introduction  15 
et al, 2006). Similar to osteoblasts, they produce proteins including OPN and OCN 
as well as dentin matrix protein 1 and proteoglycans (Schaffler MB et al, 2014). 
Osteocytes are sensitive to mechanical stresses, with elongation of their processes 
through E11/gp38 proteins in response to tissue strain. It is believed that they 
recognise mechanical stresses through hydrostatic pressure changes in the 
pericellular space (see Figure 1.1) (You J et al, 2000). In response to mechanical 
stimulation, osteocytes upregulate their secretion of a range of molecules, 
including IGF-1 (Yakar S et al, 2002) and prostaglandin E2 (Somjen D et al, 1980), 
and reduce production of others such as sclerostin (Robling AG et al, 2008), 
resulting in increased osteoblast activity. Equally, osteocytes have been shown to 
influence osteoclastogenesis, whereby apoptosis of osteocytes induce expression 
of the pro-osteoclastic cytokine receptor activator of nuclear factor kappa-B 
ligand (RANKL) in neighbouring healthy cells (Schaffler MB et al, 2014). Osteocyte 
apoptosis is influenced by biomechanical loading, further highlighting the 
importance of physical factors on cell function (O'Brien CA et al, 2013). Given their 
close interaction with both osteoblasts and osteoclasts, osteocytes clearly play a 
crucial role in bone homeostasis.  
1.5 Haematopoietic stem cells 
Haematopoietic stem cells (HSCs) are self-renewing cells that can give rise to a 
range of cell types through haematopoiesis (Wu JY et al, 2009). They are non-
adherent and round in appearance and can be found in bone marrow and 
peripheral blood (Suda T et al, 2001).  Cell types they can differentiate into 
include red blood cells, macrophages and lymphocytes (Wu JY et al, 2009).  
Within the bone marrow, HSCs are provided with a microenvironment, or niche, 
that facilitates maintenance, mobilisation and differentiation. HSCs require 
stromal cells for differentiation, a task which can be performed by cells from the 
osteoblast lineage (Wu JY et al, 2009). The exact molecular mechanism for this 
interaction is not completely defined, but studies have suggested factors such as 
OPN (Stier S et al, 2005), Notch ligand Jagged-1 (Calvi LM et al, 2003) and N-
cadherin (Haug JS et al, 2008) play a role. Furthermore, stromal cells and 
osteoblasts produce macrophage colony-stimulating factor (M-CSF) which 
promotes osteoclastogenesis further down the HSC differentiation pathway (Suda 
T et al, 2001).  
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1.6 Macrophages 
Derived from HSCs, macrophages are a white blood cell that play a crucial role in 
immunity, homeostasis and tissue repair. In response to encountering either 
damaged tissue or pathogens, molecules are produced by macrophages to exhibit 
an effect on the surrounding tissue (Mills CD, 2012). This can be categorised as M1 
or M2. M1 macrophages exert a pro-inflammatory effect through the production 
of cytokines including tumour necrosis factor alpha (TNF-α) and interleukin-1 (IL-
1). M2 macrophages conversely have anti-inflammatory effects, producing IL-10 
and ornithine to promote repair (Mills CD, 2012). This has significance for the 
success of orthopaedic implants as the phagocytosis of wear debris particles leads 
to activation of pro-inflammatory M1 macrophages (Rao AJ et al, 2012) which 
stimulate osteoclastogenesis, predominantly through M-CSF production. This 
increase in osteoclast activation can lead to loosening of the implant and failure 
(Landgraeber S et al, 2014).  
1.7 Osteoclasts  
Also part of the HSC lineage, osteoclasts act alongside osteoblasts to contribute 
to bone homeostasis. They are formed from the fusion of monocyte progenitors 
and are the only cells capable of resorbing bone (Roodman GD, 1999). They are 
multinucleated (typically around 3 – 20 nuclei) with a characteristic ruffled border 
and sealing zones that act as specialised resorbing structures. They stain intensely 
for tartrate-resistant acid phosphatase (TRAP), which is their most commonly used 
histochemical marker (Hayman AR, 2008). They are derived from macrophages 
that are prompted to proliferate, differentiate and activate in the presence of M-
CSF and RANKL, which can be produced by stromal cells and osteoblasts (Figure 
1:2). These factors are therefore required when culturing osteoclasts in vitro in 
the absence of stromal cells and osteoblasts (Marino S et al, 2014).  
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Figure 1:2 Osteoclast generation and fate. 
Osteoclasts are derived from the HSC lineage. Mononuclear precursors are promoted to proliferate 
and fuse under the action of M-CSF and RANKL, both of which are secreted by osteoblasts and 
osteocytes. M-CSF leads to the proliferation of osteoclast precursors. RANKL then stimulates these 
precursors to differentiate and fuse into multinucleated osteoclasts. Conversely, OPG – also 
produced by osteoblasts and osteocytes – has an inhibitory effect on osteoclastogenesis by acting 
as a soluble decoy receptor for RANKL. Polarisation is the process of cytoskeleton change that 
facilitates adhesion to the bone surface and, subsequently, resorption. Figure used with permission 
from Elsevier (Bellido T et al, 2014).  
1.8 Osteoclast regulatory cytokines  
Given its importance in skeletal and calcium homeostasis, osteoclasts are 
regulated by a number of cell signalling modulators. The key cytokines that affect 
activity are discussed hereafter.  
M-CSF is crucial for the development of osteoclasts. It binds to the colony 
stimulating factor 1 receptor (CSF1R) of osteoclast precursors to promote 
proliferation (Hodge JM et al, 2007) thus expanding the pool size (Jacquin C et al, 
2006). The role of M-CSF in survival of osteoclasts is less well understood, 
however, with conflicting evidence present in the literature (Fuller K et al, 1993, 
Hodge JM et al, 2007). M-CSF also causes an increase in the production of RANKL 
from osteoclast precursors (Arai F et al, 1999). Importantly, M-CSF cannot promote 
the differentiation of precursors to osteoclasts by itself (Boyce BF and Xing L, 
2008).  
RANKL promotes the final differentiation to mature osteoclasts. It binds to the 
RANK receptor on the surface of macrophage/monocyte precursors, inducing 
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downstream intracellular signals that lead to commitment to the osteoclast 
lineage (Park JH et al, 2017). This is completed through the sequential expression 
of nuclear factor kappa B (NF-κB), c-Fos and nuclear factor of activated T cells 1 
(NFATc1) (Yamashita T et al, 2007). The importance of RANKL has been 
demonstrated in mice models where deficiency leads to an absence of osteoclasts 
and high levels of macrophages (Kong YY et al, 1999). It is a member of the TNF 
family and, although highly expressed by in bone tissue, is also found in a variety 
of others including lymphoid, lung and mammary tissue (Takayanagi H, 2007). 
Secretion is mediated by either proteolytic cleavage – through MMP3 or ADAM - or 
alternative splicing (Boyce BF and Xing L 2008). Although the majority of RANKL 
production is facilitated through osteoblasts and stromal cells, T cell secretion in 
patients with inflammatory arthropathies can lead to the joint destruction seen 
in these conditions (Kearns AE et al, 2008, Boyce BF and Xing L, 2008). Given its 
involvement in both bone biology and immunity, it is a key factor in the subject 
of osteoimmunity (Kearns AE et al, 2008, Boyce BF and Xing L, 2008). Furthermore, 
RANK/RANKL have been implicated in the pathophysiology of several cancers 
(Renema N et al, 2016).  
Closely linked with RANKL is osteoprotegerin (OPG). Also a member of the TNF 
family (TNFRSF-11B), this cytokine acts to downregulate osteoclast differentiation 
and function by acting as a soluble decoy receptor for RANKL (Yasuda H et al, 
1998). It is expressed in a variety of tissues, including osteoblasts and stromal 
cells. In bone marrow, the effect of OPG is inhibited by 1,25-
dihydroxycholecalciferol and dexamethasone (Yasuda H et al, 1998) and 
upregulated by transforming growth factor-β (TGF-β) (Murakami T et al, 1998). In 
mouse models where OPG is deficient, severe osteoporosis occurred (Mizuno A et 
al, 1998), highlighting the significance of this protein in osteoclast function. 
Interestingly, OPG has been found to be significantly increased during the 
differentiation of isolated osteoclast cultures. It has been proposed that OPG 
secretion by osteoclasts may play an auto-regulatory function by inducing 
apoptosis (Kang JH et al, 2014). 
Other cytokines that have multiple roles in bone homeostasis include IL-1, IL-6 
and TNF. Early evidence demonstrated all of these cytokines strongly enhance 
osteoclasts (Lorenzo JA et al, 1987). Both IL-1 and TNF consist of two separate 
peptides (α and β) that have similar biological effects. IL-1 is the most potent 
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stimulator of bone resorption in vitro (Lorenzo JA et al, 1987) with direct (Jimi E 
et al, 1999) and indirect effects on osteoclasts through RANKL (Hofbauer LC et al, 
1999) and prostaglandin production (Sato K et al, 1986). IL-6 is produced by 
osteoblasts and stromal cells, and its production can be increased by TNF and IL-
1. It acts to increase resorption by promoting osteoclast precursors to 
differentiate into mature osteoclasts. In vivo analysis has shown TNF 
administration to raise calcium levels as a result of increased osteoclast formation 
and activity (Tashjian AH Jr et al, 1987). TNF also enhances the effects of IL-1 to 
stimulate osteoclasts. However, the effects from these cytokines on bone 
homeostasis are not restricted to osteoclasts. Recent evidence has demonstrated 
IL-1 (Lin FH et al, 2010), IL-6 (Franchimont N et al, 2005) and TNF (Glass GE et al, 
2011, Gerstenfeld LC et al, 2003) also promote osteoblast differentiation of MSCs. 
This dual role is a result of dose dependent activity, with osteogenic effects 
occurring at lower doses (Glass GE et al, 2011, Gerstenfeld LC et al, 2003). This 
can be seen in vivo during fracture healing where pro-inflammatory cytokines 
migrate to the fracture site and promote local osteogenesis (Glass GE et al, 2011). 
1.9 Osteoclast differentiation pathway  
In the progression from precursor cell to osteoclast, signalling pathways involving 
the aforementioned cytokines are crucial. RANKL binds to RANK causing the 
recruitment of TNF receptor-associated factor (TRAF) proteins, namely 1 – 6 
(Darnay BG et al, 1998). Of these, TRAF6 plays the most important role in 
osteoclast formation by activating several targets including NF-κB, c-Jun N-
terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) (Naito A et 
al, 1999, Kobayashi N et al, 2001, Wong BR et al, 1998). RANKL also strongly 
induces NFATc1 – via NF-κB and c-Fos – which is the master transcription factor 
for the terminal differentiation of osteoclasts (Novack DV et al, 2003, Kim JH and 
Kim N, 2016). The stimulation of NFATc1 is maintained as TRAF-6, NF-κB and c-
Fos pathways create a positive autoregulation system. NFATc1 in turn stimulates 
TRAP, osteoclast-associated receptor (OSCAR) and cathepsin-K, which are 
responsible for the induction of other osteoclast transcription factors (Matsumoto 
M et al, 2004, Asagiri M et al, 2005, Kim K et al, 2005). Once fully differentiated 
osteoclasts can then undertake their role in bone resorption and remodelling 
(Seeman E and Delmas PD, 2006).  
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1.10 Osteoclast attachment 
The structural appearance of osteoclasts varies depending on their functional 
state. Different states include moving, resting and absorbing (Jurdic P et al, 2006). 
The reason osteoclasts are induced to resorb specific sites is not well understood. 
A potential theory that has been proposed is that micro-fractures within the bone 
architecture resulting from mechanical loading apoptose osteocytes which in turn 
signal osteoclasts to migrate to that area (Noble BS et al, 2003). When activated, 
osteoclasts initiate a resorption cycle. This is a multistep pathway that requires 
attachment of the osteoclasts to the bone matrix. Attachment is facilitated 
through focal adhesions (Jurdic P et al, 2006). Adhesions are formed through the 
interaction between transmembrane cell receptors and surface ligands. OPN is a 
natural ligand for the vitronectin receptor in bone that accumulates along the 
bone surface to attract and bind osteoclasts (Reinholt FP et al, 1990).  
Integrins are the key group of transmembrane cell receptor responsible for 
adhesion (Väänänen K, 2005). Osteoclasts express 3 integrin extracellular matrix 
receptors: αvβ3, α2β1 and αvβ1. In particular, avβ3 has been shown to be crucial 
to attachment, migration and the formation of the tight seal required for 
resorption (Väänänen HK and Horton M, 1995). Interruption of integrin binding 
results in inhibition of bone resorption (Crippes BA et al, 1994). Downstream 
products of the αvβ3 signalling pathway have also been investigated and shown to 
be of importance. Tyrosine kinase PYK-2 is phosphorylated by αvβ3 and controls 
osteoclast attachment. It localises with its attachment protein p130cas to the 
zone of contact between osteoclasts and bone matrix (Väänänen K, 2005). 
Blocking the action of PYK-2 in animal models led to osteopetrosis without 
reduction in osteoclast numbers, highlighting its role in attachment (Nakamura I 
et al, 2001).  
Following attachment, the cell polarises. This enables alterations in the cell shape 
through changes in the actin cytoskeleton. At this stage, three F-actin and five 
vinculin distributions are formed (Väänänen HK and Horton M, 1995). Initially, 
these structures form podosomes. Podosomes are found in cells from a monocytic 
lineage, such as macrophages and osteoclasts, and are used to adhere and migrate 
to substrates (Linder S and Aepfelbacher M, 2003). Each podosome is composed of 
an F-actin cone containing activators of actin polymerisation such as such as 
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Wiskott-Aldrich Syndrome protein (WASp), Actin related protein 2/3 (Arp2/3), 
cortactin, and gelsolin (Jurdic P et al, 2006). Initially, they are organised in 
clusters that subsequently evolve into dynamic rings. With further cell maturation 
at around day seven, rings expand to the cell periphery to form longer lasting belts 
that are present in fully differentiated cells (Jurdic P et al, 2006).  
Two distinct areas are formed where the osteoclast is in contact with the bone 
matrix - a sealing zone (SZ) and a ruffled border (Väänänen HK and Horton M, 
1995). The sealing zone – adjacent to the ruffled border – provides the required 
tight attachment to the bone. It is composed of a large ring of actin as discussed 
above, around 4 μm wide (Jurdic P et al, 2006). However, the SZ is only formed 
when attached to mineralised matrix; it is not present during adhesion to glass 
during cell culture (Saltel F et al, 2004). On glass, podosomes arrange to form the 
aforementioned actin rings and belts, which are similar to the SZ but of a different 
density (Figure 1:3). The SZ is only observed when the cell is attached during 
resorption and disappears during migration (Takito J et al, 2018). The ruffled 
border is an expanded area of the membrane that serves as the exit site of protons 
and enzymes. The alteration in membrane structure allows for a greater surface 
area to be presented to the bone surface. In turn, this increases the quantity of 
secretions and resorbed particles that can pass via the ruffled border (Stenbeck 
G, 2002).  
 
Figure 1:3 Podosome patterning and sealing zone. 
Podosomes are initially organised into clusters. As osteoclast differentiation and maturation occurs, 
they subsequently alter to form rings and then belts. Belts are stabilised by acetylated microtubules. 
The sealing zone is only evident when osteoclasts are in contact with apatite crystals (e.g. on a bone 
surface) and measures approximately 4 x 4 µm, compared to the 0.5 x 1 µm podosomes found in 
rings and belts. The sealing zone is necessary for bone resorption to occur Figure used with 
permission from Elsevier (Jurdic P et al, 2006). 
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1.11 Bone resorption 
Bone resorption involves dissolution of crystalline calcium phosphate or 
hydroxyapatite and degradation of fibrillar collagen in the extra-cellular 
resorption lacunae. This process is facilitated through proteolytic enzymes and 
requires energy, ion movements and intracellular replacement of materials 
(Väänänen K, 2005).  
 
Figure 1:4 Osteoclast attachment and resorption. 
Schematic representation of a resorbing osteoclast. Osteoclasts require the presence of the sealing 
zone to firmly attach to bone and initiate resorption. This feature is only present in mature osteoclasts. 
H+ and cathepsin-K are secreted through the ruffled border, creating the acidic environment required 
to initiate breakdown of the bone matrix. Matrix degradation products are then secreted into the 
extracellular space at the functional secretory domain via transcytosis. Cytoplasmic ion equilibrium 
is maintained through ion and bicarbonate production at the basolateral membrane. FSD = functional 
secretory domain, BM = basolateral membrane, N = nucleus, RB = ruffled border, SZ = sealing zone, 
RL = resorption lacuna, H+ = hydrogen ion, CK = cathepsin-K, MDP = matrix degradation particles.  
Structurally, the ruffled border is the site of resorption. This occurs within the 
sealing zone, which provides the tight attachment required (Väänänen HK and 
Horton M, 1995). As bone matrix is primarily hydroxyapatite (Ca3(PO4)2Ca(OH)2), 
an alkaline salt, dissolution requires protonation, with approximately 2 moles of 
H+ for each mole of Ca2+. Upon attachment, acidic vesicles fuse to the bone plasma 
membrane, releasing acid. This process is maintained via a vacuolar-type proton 
pump that transports H+ from the cytoplasm (Blair HC et al, 1989). Chloride 
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channels are also present in the ruffled border to move chloride anions. 
Cytoplasmic ion equilibrium is maintained through ion and bicarbonate production 
at the basolateral membrane. Cathepsin-K is the main protease responsible for 
matrix degradation. In studies where this enzyme has been blocked, bone matrix 
contained a build-up of undigested collagen fibrils and thickening of trabeculae 
(Saftig P et al, 1998). Cathepsin-K is also thought to be responsible for the 
activation of TRAP; another key enzyme and important cytochemical marker of 
osteoclasts. In addition to bone dissolution, removal of breakdown products is 
required. Calcium, phosphate and collagen fragments are endocytosed and 
transcytosed through the cell before being secreted in to the extracellular fluid 
via a specialised region of the osteoclast – the functional secretory domain 
(Väänänen K, 2005, Nesbitt SA and Horton MA, 1997) (Figure 1:4). 
1.12 Bone remodelling 
Remodelling is a dynamic process whereby bone is removed by osteoclasts and laid 
down by osteoblasts (Langdahl B et al, 2016). This occurs continually throughout 
life, with the entire skeleton being replaced every 10 years. It relies upon a close 
interaction between osteoblasts and osteoclasts and requires a specific balance 
to maintain bone mass and quality. In cases where this balance is disturbed, 
disease states occur. For example, osteoporosis occurs when either osteoclasts 
are overactive or osteoblasts are underactive, leading to reduced bone density 
(Langdahl B et al, 2016). 
The process begins with the activation phase. Changes in the bone 
microenvironment act as a trigger. These changes include micro-fracture, 
alterations in mechanical loading and factors such as TNF-α and IGF-1. As 
previously discussed, micro-fractures potentially stimulate remodelling by 
inducing osteocyte apoptosis which in turn signal osteoclasts to migrate to the 
area (Noble BS et al, 2003). Regardless, any of the above changes in the bone 
microenvironment lead to activation of lining cells. These are cells of an 
osteoblast lineage that cover non-remodelling surfaces and are involved in the 
propagation of the activation signal that initiates resorption. The lining cells 
secrete RANKL that in turn interacts with the RANK receptor of pre-osteoclasts, 
leading to fusion and activation as detailed above (Miller SC et al, 1989).  
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Following activation, resorption occurs. This is as described above where 
osteoclasts polarise, adhere to bone and begin dissolution. Following this, bone 
lining cells then enter the resorption pits. The lineage of these cells is uncertain, 
with studies suggesting both monocyte (Tran Van P et al, 1982) and osteoblast 
lineage (Everts V et al, 2002). It is equally possible that a combination of both cell 
types are involved. They remove any collagen matrix remnants in order to prepare 
the bone surface for osteoblast-mediated formation.  The cells then produce 
osteopontin which is incorporated into the mineralised tissue (Takahashi F et al, 
2004). Finally, coupling signals are produced to facilitate the final phase of 
remodelling – formation (Raggatt LJ and Partridge NC, 2010).  
The process of resorption leads to the production of growth factors, including IGF-
1, BMP and TGF-β (Tang Y et al, 2009). These in turn assist in the recruitment of 
osteoblasts to the resorbed area. If osteoclasts are defective in their resorption, 
leading to these growth factors not being released, osteoblasts are still recruited. 
It is likely this is a result of coupling factors being produced by osteoclasts (Martin 
TJ and Sims NA, 2005). These factors rely on both direct contact between cells 
and soluble signals to stimulate osteoblastogenesis. Osteoblasts then produce 
initially uncalcified matrix (osteoid) made primarily of type 1 collagen as well as 
non-collagenous proteins. Finally, hydroxylapatite is incorporated to mineralise 
the matrix which completes the resorption cycle (Raggatt LJ and Partridge NC, 
2010).  
1.13 Bionanotechnology 
Advances in technology have frequently produced breakthroughs in science and 
medicine. Nanotechnology represents one such area. This is generally defined by 
technologies that work with dimensions of 1 - 100 nm (nm = 10-9 m) (Kulkarni RP, 
2007). It has been subject to intensive development, with a national initiative to 
promote this research in the United States since the 1990’s. Through their National 
Nanotechnology Initiative (NNI), the US has spent $19.4 billion between 2000 – 
2014 (Sargent JF, 2014). Consequently, nanotechnology has found applications is 
a variety of fields from physics to biology (i.e. bionanotechnology) (Kulkarni RP, 
2007). 
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The origins of bionanotechnology can be considered to trace back to the 
identification of DNA molecular structure in 1953. This and subsequent research 
led to an increased understanding of the reactions which drive protein production 
from DNA (Alberts B et al, 2002). Given the majority of these reactions occur on 
the nanoscale it was an intuitive progression to develop technologies that 
manipulate cell function on this level. At present, research has focussed on 
synthetic nanomaterials and nanoparticles as well as the investigation of 
nanostructures such as pores. It is hoped these areas will facilitate advancements 
in diagnostics, treatments and tissue regeneration (Etheridge ML et al, 2013).  
Currently, the role of bionanotechnology in healthcare has been limited. An 
exception to this is cancer research where new diagnostic methods and treatments 
have been more heavily investigated. The ultimate aim for many of these studies 
has been the ability to identify cancerous cells at their earliest stage and precisely 
target them to maximise effectiveness and minimise side effects (Kulkarni RP, 
2007). Given the rapid expanse in research, it is likely that the range of medical 
applications for nanotechnology will increase.  
1.14 Tissue engineering and regenerative medicine 
Tissue engineering and regenerative medicine (TERM) refers to a broad field of 
investigation ranging from the molecular level to whole organ systems within the 
body. There is considerable overlap between tissue engineering and regenerative 
medicine, although the later often implies the use of stem cells as the source 
(Berthiaume F et al, 2011).  The ultimate goal of TERM is to enhance our 
understanding and management of degenerative and disease states affecting the 
body. This can be applied to humans either directly, for example through the 
implantation of graft tissues, or indirectly via the testing of new drug therapies 
and precision medicine on engineered tissues (Wobma H and Vunjak-Novakovic G, 
2016).  
The first engineered tissue was skin. Epidermis was grown from biopsies harvested 
from patients and co-cultured with mouse mesenchymal cells (Green H et al, 
1979). This allowed the production of sheets of tissue that could be applied to 
areas of significant skin loss, such as following burns. These and subsequent 
studies effectively introduced the basic principles of tissue engineering. Organs 
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and tissues that have been targeted have typically been those prone to injury or 
degeneration, or those with limited regenerative potential. Examples include 
cornea, neural tissue, pancreas, cartilage and kidney (Shafiee A and Atala A, 
2017). Supplying adequate cells or tissue to fulfil the required function is clearly 
important. Stem cells have therefore played a central role in this field given their 
potential for high rates of proliferation and pluripotency (Berthiaume F et al, 
2011).   
Harvesting the correct cell type represents one part of the solution. Equally 
important is that of the cell environment, both with regard to the chemical and 
physical aspects. These factors are important for cell stimulation, function and 
survival (Engler AJ et al, 2006). For example, in the production of engineered liver 
tissue, cells require low fluid sheer stresses (Park J et al, 2005) and the addition 
of growth factors such as TGF-α and hepatocyte growth factor (Nagy P et al, 1996). 
The addition of scaffolds represents a further addition to the cell environmental 
that can enhance growth. Cell scaffolds allow for cell attachment and migration 
and offer a form of mechanical stability that is often found in the native tissue. 
They can either be synthetic (for example poly(e-caprolactone) (Dong L et al, 
2017)) or natural (for example collagen). Given that collagen is such a crucial 
component of bone, it has significant potential for use as a scaffold in the 
culturing cells to produce bone graft (Nguyen BB et al, 2017).  
With advances in technology across a range of fields, such as bionanotechnology, 
further developments in TERM have occurred. These include the production of 
precision-engineered surfaces that have embossed nanoscale features which 
promote osteogenesis (Dalby MJ et al, 2014) and altering matrix stiffness to guide 
cell fate (Engler AJ et al, 2006). Such studies have further cemented the link 
between the cell’s environment and its ultimate fate. This has led to the 
investigation of other parameters that can be altered to manipulate cell 
differentiation and proliferation.  
1.15 Bone tissue engineering 
Bone represents the second most commonly transplanted tissue after blood (Wang 
W and Yeung KWK, 2017). It is required in a range of surgical procedures, across 
specialities including orthopaedic and maxillofacial surgery. Generally, bone graft 
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is utilised to assist in the management of healing defects, such as non-unions, 
where the bone has failed to heal properly following trauma (Delloye C et al, 
2007). Within the United States, $2.5 billion is spent annually on the management 
of bone defects (Amini AR et al, 2013). With the ageing population, it is likely this 
requirement will rise (Giannoudis PV et al, 2011) given that osteoporotic fractures 
are common in this demographic and do not heal as readily as those sustained in 
normal bone (Tarantino U et al, 2011). 
At present, the most common graft sources are autograft (i.e. from the same 
individual) and allograft (i.e. from an individual genetically different to the 
recipient) (Wang W and Yeung KWK, 2017). Autograft represents the gold standard 
as they are not associated with immune reactions and contain osteogenic 
components, including MSCs and growth factors, as well as the required bony 
scaffold for osteoconduction (Delloye C et al, 2007). They have several limitations, 
however. Firstly, harvesting of the graft requires a second procedure at a different 
site, typically the iliac crest. This can be a source of significant morbidity for the 
patient. Complications that have been documented include significant pain, 
neurovascular injury, pelvic fracture, herniation of abdominal contents, ureter 
injury and infection (St John TA et al, 2003, Ebraheim NA et al, 2001). 
Furthermore, the volume of graft that can be harvested may be insufficient to 
treat the defect (Amini AR et al, 2013). Finally, they have high direct and indirect 
costs (St John TA et al, 2003). Allograft has the advantage of being available in a 
range of forms, such as chips and whole bone segments, however comes with a 
greater risk of adverse immune reactions and infection transmission (Wang W and 
Yeung KWK, 2017). Furthermore, given that the graft requires irradiation or 
freeze-drying prior to implantation (Delloye C et al, 2007), most of the 
osteoinductive factors are lost, ultimately reducing the effectiveness (Sohn HS 
and Oh JK, 2019). In the case of both auto- and allograft there are mixed opinions 
within the literature as to whether there is sufficient supply. There is certainly a 
perception amongst surgeons that there are insufficient stocks of banked bone 
graft (Greenwald AS et al, 2001), however a relatively recent paper has reported 
that, in the United Kingdom at least, this may not be the case (Lomas R et al, 
2013). Regardless, taken alongside the aforementioned disadvantages, alternative 
sources of bone graft have been sought.  
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The production of tissue engineered bone graft represents an attractive option to 
the above problem. As such, this has been an area of scientific interest for a 
number of decades (Amini AR et al, 2013). The ultimate aim of bone tissue 
engineering is the production of readily available ‘off the shelf’ bone that avoids 
the issues of donor site morbidity, immune reactions and limited osteoinduction. 
Important factors in the fulfilment of this goal include 1) a scaffold to support cell 
growth, similar to bone extracellular matrix, 2) osteogenic cells, 3) morphogenic 
signals to influence the route of cell differentiation and growth, and 4) nutrient 
supply and waste removal (Amini AR et al, 2013). At present, the production of 
small volumes of tissue within the laboratory setting is possible, however larger 
production for clinical use represents a greater challenge. Bioreactors represent 
an option to potentially combat this shortcoming.  
1.16 Mechanotransduction 
Mechanical forces instigate changes to biological systems across a range of scales, 
ranging from a cellular level – for example in actin-myosin complexes – to the 
entire body, as with gravity. Such forces have a significant effect on the formation 
and maintenance of tissues (He L and Montell D, 2012). Equally, any deficiency 
can lead to disease states, such as osteoporosis (Hoffman BD et al, 2011). The 
effect of force on bone and remodelling has been long established, as set out in 
the 19th Century in Wolff’s law (Frost HM, 1994). At the time, however, the 
mechanism through which organisms respond and adapt to mechanical loads was 
not known (Frost HM, 2004).  
At a cellular level, mechanical forces can have either a direct or indirect effect 
on cells. Indirect mechanisms require biochemical stimulation, whereas direct 
involve mechanically stimulating the nucleus. In most scenarios, there is likely to 
be elements of both direct and indirect mechanisms (Janmey PA and Miller RT, 
2011). The process through which cells respond to mechanical stimulation is called 
mechanotransduction (Wang N et al, 2009).  
Integrins are a group of adhesive transmembrane receptors that link the 
extracellular matrix (ECM) to the internal cytoskeleton of the cell (Goldmann WH, 
2012). They transmit forces from the ECM to the actin cytoskeleton and vice versa. 
The ability to apply force from the cytoskeleton to the ECM is crucial for cell 
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migration and adherence. In the process of attaching to the cytoskeleton, 
integrins produce a 2 pN increase in adhesion strength between the ECM and the 
cytoskeleton (Jiang G et al, 2003). These adhesions produced between the ECM 
and integrins creates micro-projections, termed lamellipodia and filopodia, which 
progress to form focal complexes (FC) (Katsumi A et al, 2004). The development 
from adhesion to FC requires the recruitment of vinculin, which regulates 
migration and adhesion. Further maturation of FC can occur, leading to the 
production of larger focal adhesions (FA) through Rho-dependent mechanisms 
(Galbraith CG et al, 2002). FC are typically 1 µm in size, compared to >5 µm for 
super-mature FA (Coyer SR et al, 2012). FA consist of three layers: 1) signalling 
layer, composed of integrins, focal adhesion kinase (FAK) and paxillin which 
initiate biochemical signalling, 2) a force transduction layer containing talin and 
vinculin, and 3) an actin regulatory layer comprised of vasodilator-stimulated 
phosphoprotein (VASP), zyxin and α-actinin (Kanchanawong P et al, 2010). These 
layers which make up the FA link actin fibres to the main contractile stress fibres 
of the cell, facilitating the transfer of force from a nanoscale to microscale signal 
transducer (Dalby MJ et al, 2014).  
Ultimately, the signals passed through the cytoskeleton interact with the nucleus, 
leading to alterations in gene transcription (Ostlund C et al, 2009). Specifically, 
tension changes produce signalling alterations in the RhoA kinase pathway (ROCK), 
FAK and ERK (Xiao G et al, 2002, Nikukar H et al, 2013). These cascades are 
involved in the regulation of transcription factors, including runt-related 
transcription factor 2 (RUNX2), that alter expression of bone-specific genes such 
as OCN (Xiao G et al, 2002, Nikukar H et al, 2013).  
The ability to alter the production of FA has been a focus of tissue engineering 
research as this has been shown to alter MSC phenotype and differentiation (Dalby 
MJ et al, 2014). Specifically, smaller adhesions result in adipogenesis (McBeath R 
et al, 2004), whereas larger adhesions promote osteogenesis (Kilian KA et al, 
2010a). This is thought to be in part due to the geometry of osteoblasts, which 
are typically large and well spread (Nikukar H et al, 2013). Such geometric 
features require a highly contracted cytoskeleton in order to support the cell 
structure. As such, larger FA are required in order to facilitate the increased 
tension as dictated by their force-balance relationship (Nikukar H et al, 2013).  
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In addition to FA, ion channels play an important role in the transduction of 
mechanical stimuli. Piezo1 and piezo2 induce mechanically activated cationic 
currents in cells (Coste B et al, 2012). When exposed to strain, they facilitate Ca2+ 
influx into cells (Lee W et al, 2014). Similarly, members of the transient receptor 
potential (TRP) cation channel family are activated by mechanical stimulation 
(Tsimbouri PM et al, 2017b). Following activation, they produce adaptations in the 
cell cytoskeleton (Kuipers AJ et al, 2012). TRPV1 has been demonstrated to be the 
most mechanosensitive protein to nanostimulation. It has downstream effects on 
protein kinase C (PKC) as part of the TRPV1-PKC-Wnt/β-catenin axis (Tsimbouri 
PM et al, 2017b). β-catenin directly upregulates RUNX2 to stimulate bone 
formation (Gaur T et al, 2005). Another member of the TRP group, TRPV4, 
regulates Ca2+ influx in osteoclasts, mediating their differentiation and survival. It 
is not clear what the in vivo stimuli for TRPV4 activation in osteoclasts are, 
however (Masuyama R et al, 2008). 
1.17 Bioreactors  
The main function of bioreactors is to accelerate tissue growth (Partap S et al, 
2010). By definition, they employ mechanical forces to influence biological 
processes. By stimulating cells to differentiate and mature according to a 
predetermined objective this allows optimisation of the tissue prior to 
implantation (Partap S et al, 2010). As the cells are cultured in a controlled and 
optimised environment this assists in up-scaling tissue production. Several designs 
have been examined within the literature. This includes spinner flasks, rotating 
wall bioreactors and perfusion bioreactors.  
In the spinner flask, a magnetic stirrer attached to the bottom of the flask 
produces convective forces. Cells are suspended from needles within a scaffold. 
The turbulent currents that are produced improve media flow around the cells 
(Partap S et al, 2010). Studies have demonstrated this results in increased 
osteogenic cell proliferation and gene expression (Goldstein AS et al, 2001, Partap 
S et al, 2010, Korin N et al, 2009). This bioreactor also has the advantage of being 
relatively inexpensive. However, it can lead to uneven cell distribution within the 
scaffold, with clumping of cells at the periphery (Partap S et al, 2010). 
Furthermore, the unequal distribution of convective forces within the flask (Bjerre 
L et al, 2011) can lead to disparities in the osteogenic effect.  
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Rotating wall bioreactors were initially designed by NASA to protect cell cultures 
from the extreme forces of shuttle take-off (Partap S et al, 2010). In this 
bioreactor, the walls rotate to produce an upward drag force and corresponding 
downward gravitations force, which balance the suspended cell scaffold in the 
centre of the media (Partap S et al, 2010). The low degree of sheer and high 
nutrient flow/waste removal aids cell culture. The effect of this bioreactor on 
osteogenesis is not clear, however, with both positive (Song K et al, 2013, Pollack 
SR et al, 2000) and negative (Goldstein AS et al, 2001, Sikavitsas VI et al, 2002) 
findings being described. This may be partly related to limited nutrient transfer 
to the centre of the scaffold and the osteogenic effect being focussed on the 
periphery (Sikavitsas VI et al, 2002). 
Flow perfusion bioreactors aim to reduce the issues with uneven cell distribution 
noted in the above two bioreactors. In this system media is pumped by a peristaltic 
roller through the cell scaffold which is held in a chamber that directs fluid flow 
(Partap S et al, 2010). Histological examination of seeded scaffolds exposed to 
flow perfusion demonstrates an equal distribution of cells. The flow rate and 
character (e.g. continuous, cyclic) can be varied, both of which have been shown 
to be important factors in upregulating osteogenesis (Li P et al, 2012, Wittkowske 
C et al, 2016).  Limitations to perfusion bioreactors include their complex setup 
and the inability to upscale to larger cell scaffolds for clinical use (Gardel LS et 
al, 2014).  
The aforementioned bioreactors have all utilised external forces in an attempt to 
provide a positive influence on osteogenesis. Although each has demonstrated 
positive results, there have been significant drawbacks to each that ultimately 
limit their effectiveness in delivering the goal of bone graft production. These 
technologies highlight the need for a simpler form of bioreactor that can be up-
scaled for clinical use.  
1.18 Nanokick bioreactor 
Collaboration between the University of Glasgow and the University of Strathclyde 
has led to the development of a new bone bioreactor, called the Nanokick (Figure 
1:5). This bioreactor aims to stimulate osteogenesis by transferring nanoscale 
vibrations to cell cultures. This is achieved primarily through the reverse piezo 
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effect. The reverse piezo effect is the generation of mechanical force from 
electrical energy, with the direct piezo effect being the opposite reaction 
(Tsimbouri PM et al, 2017b). There are several materials which exhibit the piezo 
effect, including bone (Cerrolaza M et al, 2017a).  
 
Figure 1:5 The Nanokick bioreactor. 
The third generation Nanokick bioreactor and associated power supply.  
In the Nanokick, ceramic piezo devices are used to achieve high frequency, low 
amplitude displacements. These vertical displacements are typically around 30-
40 nm at 1000 Hz. This frequency was chosen as it was found to be optimal for 
osteogenesis (Nikukar H et al, 2013). Furthermore, the optimal piezoelectric 
frequency for bone is in the kilohertz range (Håkansson B et al, 1994). The 
amplitude of 30-40 nm was utilised as recent studies demonstrated this promoted 
osteoblastogenesis in MSCs (Nikukar H et al, 2013, Pemberton GD et al, 2015). 
Equally, nanotopography research has demonstrated features at this scale are 
osteogenic (Dalby MJ et al, 2014). The piezo devices – of which there are 13 per 
bioreactor – are attached to a base plate composed of aluminium bonded with 
magnetic stainless steel (Figure 1:6). By coupling standard cultureware with 
magnets, this allows for firm attachment to the Nanokick bioreactor and thus 
ensures transfer of the nanoscale vibrations. Underneath the piezo devices is a 
metal baseplate to provide a large mass, ensuring displacement is upwards 
(Nikukar H et al, 2013). This setup has several advantages. Firstly, magnetically 
attaching plates to the bioreactor facilitates easy plate removal for cell feeding. 
Also, by using standard plates that rely of familiar culture techniques this reduces 
consumable costs and technique complexity. In turn, this limits issues with 
sterility that come with complex set-ups and autoclaving reusable components. 
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Finally, the bioreactor can be up-scaled based on its modular design to allow for 
greater throughput.  
 
Figure 1:6 Piezo layout and FEA analysis. 
A – diagram of the 13 piezo arrangement. This layout was found to produce the most consistent 
displacements across the top plate. Note a checkerboard layout rather than aligned rows was 
utilised, as that latter can lead to areas of reduced displacement. B – Finite element analysis 
performed with ANSYS workbench demonstrating predicted displacements with 13 piezo 
arrangement. Presented with permission of the authors (Campsie P et al, 2019).  
Recent publications have demonstrated the efficacy of the Nanokick bioreactor in 
stimulating osteogenesis (Pemberton GD et al, 2015). Pemberton et al combined 
nanoscale vibration and nanotopography to assess their effect on osteogenesis. 
MSCs were vibrated at 1000 – 5000 Hz with 16 – 30 nm vertical displacements. They 
noted increases in osteogenic genes, including OCN, OPN and BMP-2. Protein 
analysis suggested nanoscale vibration was more stimulatory than nanotopography 
alone. They noted little benefit in frequencies above 1000 Hz, whilst going below 
500 Hz did not stimulate osteogenesis (Pemberton GD et al, 2015).  
Nikukar et al exposed MSCs to nanoscale vibration between 25 – 1000 Hz. They 
demonstrated increased cell spreading, increased proliferation and increased F-
actin stress fibres at 1000 Hz (Nikukar H et al, 2016). In a separate study (Nikukar 
H et al, 2013) the authors illustrated that 500 Hz leads to changes in gene 
expression but did not alter BMP-2 and RUNX2 suggesting this frequency was not 
sufficient to promote osteogenesis. Conversely, 1000 Hz produced significant 
changes in BMP-2 and RUNX2.  This frequency also led to greater cell spreading 
and larger FA, indicative of increased intracellular tension. Furthermore, the 
ROCK pathway was shown to be stimulated. Stimulation below 500 Hz did not 
produce any significant change (Nikukar H et al, 2013). 
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Tsimbouri et al examined the effect of nanovibrations in 3D collagen gel scaffolds. 
These gels were found to transmit the vibrations produced to the contained cells. 
They demonstrated that the bone marrow stromal cells exhibited an upregulation 
of osteogenic markers, including osterix, alkaline phosphatase and OPN. It was 
noted that inhibition of the ROCK pathway downregulated gene expression, but 
this was to a lesser extent than in 2D models. Further investigation into the 
underlying mechanism revealed that the TRVP1-PKC-Wnt/β-catenin axis played a 
significant role in osteogenesis. This suggests mechanosensitive ion channels in 
addition to adhesion and cytoskeleton tension are important in 3D models 
(Tsimbouri PM et al, 2017b).  
1.19 Hypothesis 
It has been established that mechanical forces represent a crucial factor in 
influencing cell differentiation and survival. Multiple studies have highlighted that 
increasing intracellular tension through a variety of means can promote 
osteogenesis in MSCs. It has also been demonstrated that osteoblasts and 
osteoclasts are both crucial for the process of normal bone remodelling, with 
imbalances in the function of either leading to disease states. Furthermore, there 
exists significant co-dependence between these two cell types, with significant 
overlap in regulatory cytokines and growth factors. Investigation into the effect 
of nanoscale vibration on osteoclastogenesis is therefore required. It is 
hypothesised that nanoscale vibration will promote osteogenesis without 
upregulating osteoclastogenesis.  
1.20 Aims 
The aim of this study is to examine the effect of exposing osteoclasts to nanoscale 
vibration through use of the Nanokick bioreactor. This will be undertaken in two 
culture models. Firstly, a culture of macrophages and osteoclasts, and secondly a 
co-culture of both osteoblasts and osteoclasts. Given the need for tissue 
engineered bone graft, the aim will be to stimulate osteogenesis without 
upregulating osteoclastogenesis. 
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 Materials and methods 
2.1 Introduction  
In this section, the methods involved in establishing cell cultures, bioreactor 
calibration and experimental analyses will be discussed. As aforementioned, one 
benefit of the Nanokick bioreactor is the ability to use standard cell culture 
techniques. As such, the details below represent the standard tissue culture 
principles employed by most laboratories. Sterile conditions were maintained 
throughout through the use of lab coats, gloves and class II biological safety 
cabinets cleaned with 70% ethanol before each use. The Nanokick bioreactors 
were kept in incubators at 37°C and 5% CO2 for the duration of each experiment. 
Removal was only performed to carry out calibration. The cable connecting the 
bioreactor to the external power supply was passed outside the incubator through 
the door seal to avoid disturbing the conditions. 2D cell cultures refers to the 
standard seeding of cells directly on to culture plates. 3D cultures involve mixing 
cells into a type 1 collagen gel prior to pipetting on to the plate. For experiments 
with multiple donors, each donor was seeded separately and analysed 
independently prior to pooling of results for statistical analysis.  
2.2 2D cell culture technique 
2.2.1 CD14+ Isolation 
Buffy coats – the fraction of blood containing white blood cells and platelets – 
were received from the Scottish National Blood Transfusion Service. These were 
diluted 1:1 with phosphate buffered saline (1 x PBS) and mixed by inversion. In a 
15 ml conical centrifuge tube 10 ml of buffy coat/PBS were overlaid on 4 ml of 
Ficoll-Paque (Sigma-Aldrich, Dorset, UK) at room temperature and centrifuged at 
400 x gravity (g) for 30 minutes. After centrifugation, the monocyte layer was 
aspirated using a Pasteur pipette and transferred to a 50 ml conical centrifuge 
tube, before resuspending the cells with addition of 1 x PBS to 50 ml total volume. 
The cells were washed twice with PBS and centrifuged at 200 x g for 10 minutes 
for platelet exclusion. The monocyte pellet was resuspended with 10 ml specific 
cell separation media (2% foetal bovine serum (FBS) and 1 mM EDTA in 1 x PBS) 
and mixed. A cell count was then performed with a 10 x dilution (10 µl cells added 
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to 80 µl 1 x PBS and 10 µl trypan blue) using a haemocytometer. Cells were further 
centrifuged at 350 x g for 5 minutes and resuspended to obtain 1 x 108 cells/ml. 
The suspension was transferred to a 6 ml round bottomed polystyrene tube. 
Magnetic selection was performed using EasySep Human CD14 positive selection 
kit (Stemcell Technologies, Cambridge, UK). 100 µl/ml of CD14 positive selection 
cocktail was added and incubated at room temperature for 15 minutes. Magnetic 
nanoparticles were vortexed and 50 µl/ml added before incubating at room 
temperature for 10 minutes. The suspension was made up to 2.5 ml with the 
addition of cell separation buffer and the tube placed in a specialised magnet for 
5 minutes. The magnet was then inverted to pour off the negative fraction. The 
tube was removed from the magnet and a further 2.5 ml cell separation buffer 
added prior to placing back in the magnet for a further 5 minutes. This process 
was repeated a further two times. The cells were finally re-suspended at 1 x 106 
cells/ml in alpha minimum essential media (α-MEM) supplemented with 10% FBS, 
0.02 mM L-glutamine, 10 U/ml Penicillin, and 0.1 μg/ml Streptomycin. This cell 
concentration was chosen based on publications relating to osteoclast culture 
from monocytes (Toyosaki-Maeda T et al, 2001) and work carried out by other 
researchers in the department who found this to be optimal for osteoclast 
differentiation.  
2.2.2  2D CD14+ culture 
Following suspension at 1 x 106 cells/ml, 25 ng/ml of recombinant human M-CSF 
(Peprotech, London, UK) was added. Cells were plated in 24 well plates and 
incubated overnight at 37°C and 5% CO2. After approximately 18 hours incubation 
25 ng/ml of human RANKL (Peprotech, London, UK) was added to a proportion of 
the wells. These concentrations of M-CSF and RANKL were chosen based on work 
carried out by other researchers in the department. They demonstrated that 25 
ng/ml was optimal for osteoclast growth. This value is in keeping with other 
studies in the literature (Marino S et al, 2014). Those wells with M-CSF and no 
RANKL were used as a negative control of osteoclastogenesis. Medium was 
refreshed on days 4 and 7 if required.  
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2.2.3  MSC/BMHC isolation  
Human bone marrow was aspirated from patients undergoing elective hip and knee 
arthroplasty and stored for transfer (1 x PBS, 0.53 mM EDTA, and antibiotics (6.74 
U/ml Penicillin-Streptomycin, 0.2 μg/ml Fungizone)). The bone marrow aspirate 
was diluted with 10 ml modified Dulbecco’s Modified Eagle Medium (mDMEM) 
(DMEM (D5671), 10% FBS, 100 mM sodium pyruvate, 200 mM L-glutamine 
(Invitrogen, Paisley, UK), and antibiotics). This was then centrifuged at 350 x g 
for 10 minutes, repeated twice. The cell pellets were re-suspended in mDMEM and 
overlaid on a Ficoll-Paque gradient. This was then centrifuged at 450 x g for 45 
minutes (with no speed brake) and the subsequent mononuclear interface layer 
aspirated and resuspended in mDMEM. The cells were washed a further three times 
and plated at a density of 1 x 106 in a 75 cm2 vented cell culture flask and 
incubated at 37°C with 5% humidified CO2.  
2.2.4  2D MSC/BMHC co-culture 
At day 3 non-adherent cells were removed and cultured separately at a density of 
1 x 106 in a 75 cm2 vented flask and incubated at 37°C with 5% humidified CO2, 
with three times weekly media change. This non-adherent fraction contained 
mainly bone marrow haematopoietic cells (BMHC), macrophages and osteoclast 
precursors. The remaining adherent cells were assumed to be MSCs, 
osteoprogenitors, osteoblasts and osteocytes and were cultured for a further 7 - 
10 days until an approximately 80% confluent layer was obtained. The adherent 
cells were then detached with 0.05% trypsin/0.53 mM EDTA, centrifuged and 
resuspended in mDMEM to a concentration of 3 x 104 cells/ml. 1 ml of cell 
suspension/well was pipetted onto a 24 well plate. The media was replaced on 
day 3. At day 7, 1 ml of BMHC suspension/well was added at a concentration of 
1.2 x 105/ml. These cell concentrations were chosen based on published work on 
the co-culture technique (Young PS et al, 2015). This co-culture was maintained 
with media changes three times a week.   
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2.3 3D cell culture technique 
2.3.1 3D CD14+ culture 
CD14+ cells were isolated as per the 2D technique laid out above. They were then 
centrifuged at 400 x g for 5 minutes to produce a cell pellet. The cells were then 
resuspended in 10% FBS and 10 x DMEM (Sigma-Aldrich, Dorset, UK). The collagen 
gel was then prepared, with the total volume required to produce a concentration 
of 1 x 106 cells/ml. This stage of the experiment was performed on ice to avoid 
the gel setting early. Sodium hydroxide (NaOH) was combined with rat tail 
collagen (Sigma-Aldrich, Dorset, UK). The resuspended cells were then added to 
the NaOH/collagen mix.  1 ml of gel/cell suspension was then pipetted onto each 
well of a 24 well plate. Plates were then placed in an incubator (37°C and 5% CO2) 
for 30 minutes to allow the gels to set. 1 ml of α-MEM (supplemented with 10% 
FBS, 0.02 mM L-glutamine, 10 U/ml Penicillin, and 0.1 μg/ml Streptomycin) 
containing 25 µl/ml M-CSF was then added on top of the gels. After 18 hours 
RANKL, at a concentration of 25 µl/ml, was added to a proportion of the wells. 
Those wells with M-CSF and no RANKL were used as a negative control of 
osteoclastogenesis. Media was replaced on days 4 and 7 as required.  
2.3.2  3D co-culture 
Human bone marrow was processed as described in for 2D above. At day 3, non-
adherent cells were removed and cultured separately. Both adherent and non-
adherent flasks were cultured until a confluent layer was achieved. In the 2D 
model, adherent cells were plated first, with non-adherent cells being added after 
7 – 10 days. Given it would not be possible to add additional cells once the gel had 
set, cells from both flasks were combined prior to combining with the gel. The 
adherent cells concentration was 3 x 104 cells/ml and the non-adherent 
concentration 1.2 x 105 cells/ml as per the 2D model. Cells were detached with 
0.05% trypsin and counted. They were then centrifuged at 400 x g for 5 minutes 
to produce a cell pellet. The cells were then resuspended in 10% FBS and 10 x 
DMEM before adding to the NaOH/collagen mix. Further NaOH was added drop-
wise while agitating the mix until the colour changed from yellow to pink, 
indicating the correct pH had been achieved. 1 ml of gel/cell suspension was then 
pipetted onto each well of a 24 well plate. Plates were then placed in an incubator 
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(37°C and 5% CO2) for 30 minutes to allow the gels to set. 1 ml of mDMEM was 
subsequently added on top of the gels (Figure 2:1) and replaced three times per 
week.  
 
Figure 2:1 3D culture technique. 
Schematic representation of 3D culture technique for both cell types. Cells were isolated for each of 
the CD14+ and co-culture as detailed in the 2D technique. Cells were then mixed into a type 1 
collagen gel. The gels containing cells were seeded on to 24 well plates and left to settle for 30 
minutes. Following this, media +/- growth factors were pipetted on top of the gels. Figure A represents 
the CD14+ culture, where M-CSF +/- RANKL was included in the media. Figure B illustrates the co-
culture. 
2.4 Vibration production and measurement 
Following cell isolation and plating, samples were splint into a nanoscale vibration 
(“nanokick”) and control group. For those in the nanokick group, self-adhesive 
magnetic sheets were applied to the base of the plate before cell seeding, 
ensuring all wells were covered. This allowed for coupling with the Nanokick 
bioreactor. In this study, the third generation bioreactor was utilised (Tsimbouri 
PM et al, 2017a). This differed from previous incarnations in both appearance and 
ease of use. In addition to a slimmer profile, ergonomic handles were added to 
the sides of the bioreactor, making lifting in and out of incubators by the user 
easier. Vibration production also no longer required a multistep process with 
manual input of frequency and amplitude into an amplifier. Instead, the 
bioreactor is connected to an amplifier with one switch that, when on, is 
programmed to deliver 30-40 nm vertical displacements at 1000 Hz.  
To ensure accurate and reproducible vibration delivery, the bioreactors are 
calibrated at regular intervals. This is performed using laser interferometry, which 
is used in a range of other scientific fields, including gravitational wave astronomy 
 
A B 
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(Abbott BD et al, 2009). These devices are highly sensitive, and can detect 
displacements in the order of 10-20 m. The device used in this study was the Model 
ST-S 120, (SIOS Meßtechnik GmbH, Ilmenau, Germany), which can detect 
displacements of 0.1 nm (Figure 2:2). A helium-neon laser is directed vertically 
towards the culture plates, which are in turn reflected back allowing detecting of 
vertical displacement changes. Ensuring correct alignment of the reflected beam 
is achieved by passing the signal through an oscilloscope and obtaining a ring-
shaped trace. The signal is then passed to a data processing unit, which can select 
the desired frequency (i.e. 1000 Hz) and plot the corresponding amplitude. Each 
well in a 24 well plate was measured three times and mean displacements for 
each well calculated. The principles of laser interferometry are presented in 
Figure 2:3. 
 
Figure 2:2 Laser interferometry set-up. 
The bioreactor and magnetically attached culture plate are place on an optical isolation bench, which 
reduces background vibration to limit interference. Prismatic tape is present in the base of each well 
which reflects the laser beam back towards the head and facilitates measurement of the vertical 
displacement.  
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Figure 2:3 Principles of laser interferometry. 
A - A light beam is emitted from the laser and is subsequently split into two separate arms travelling 
at 90 degrees to one another. Each beam then reflects off a mirror and is returned towards the beam 
splitter. Both beams then recombine and travel towards the photodetector. In doing so, an 
interference pattern is produced depending on how well aligned they are. Their alignment is 
dependent on the difference in distance each beam has travelled. If one beam has travelled further, 
it will take longer to return to the photodetector. If both arms of the beam are the same length, each 
will cancel the other out i.e. destructive interference. Alternatively, differences in length result in 
constructive interference, leading to the emission of light that is identified by the photodetector. The 
interferometer can identify displacements of 0.1 nm (Campsie P et al, 2019) Figure produced by Dr 
Paul Campsie. B – diagrams illustrating complete constructive and destructive interference. 
2.5 TRAP staining  
TRAP (Tartrate-Resistant Acid Phosphate) was used as per manufacturer’s 
instructions (Acid Phosphatase, Leukocyte (TRAP) kit, No.387A, Sigma-Aldrich, 
Dorset, UK). Fast Garnet solution (25 μl Fast Garnet and 25 μl Sodium Nitrite) was 
mixed by inversion for 30 seconds and left to stand for 2 minutes. 400 μl of fixative 
(12.5 ml Citrate solution, 32.5 ml Acetone and 5 ml Formaldehyde) was added to 
the base of each well for 30 seconds. This was then washed three times with warm 
water. 400 µl TRAP staining solution (4.5 ml warm water, 50 μl Fast Garnet 
solution, 50 μl Napthol, 200 μl Acetate, 250 μl Tartrate) was added and incubated 
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at 37°C for 30 minutes in the dark. The TRAP staining solution was then removed. 
Samples were washed three times with warm water and allowed to air dry. 
Digital images of the wells were acquired using an EVOS® FL Auto 2 Cell Imaging 
System (Thermo Fisher Scientific, Loughborough, UK). Osteoclasts were identified 
as TRAP positive cells with ≥3 nuclei and quantified by both number and area using 
Fiji software (Image J). Cell numbers were determined by counting all osteoclasts 
in the entire well of each replicate. Area was calculated by manually delineating 
the cell border of 100 cells/well and using the area calculation tool in Image J. 
2.6 Immunofluorescence 
Co-culture samples were cultured for 28 days. Cells were fixed (4% formaldehyde, 
1 x PBS with 1% sucrose) at 37°C for 15 minutes. The samples were washed with 
PBS and a permeabilising buffer (10.3 g of sucrose, 0.292 g of NaCl, 0.06 g of 
MgCl2, 0.476 g of HEPES buffer, 0.5 ml of Triton X, in 100 ml of deionised water, 
pH 7.2) at 4°C for 5 minutes, then incubated at 37°C for 5 minutes in 1% bovine 
serum albumin (BSA)/ 1 x PBS. The BSA/PBS was removed and different antibodies 
added for one hour at 4°C. Specific primary antibodies used were: 
Vimentin (1:50 in 1% BSA/1 x PBS) 
Tubulin (1:50 in 1% BSA/1 x PBS) 
Vinculin (1:150 in 1% BSA/1 x PBS) 
Simultaneously, rhodamine-conjugated phalloidin was added for the duration of 
this incubation (1:100 in 1% BSA/1 x PBS, Thermo Fisher Scientific, Loughborough, 
UK). The samples were then washed in 0.5% Tween 20/PBS at 37°C for 5 minutes. 
A secondary antibody – anti-mouse IgG (1:50 in 1% BSA/1 x PBS, Vector 
Laboratories, Peterborough, UK) – was added for 1 hour at 37°C followed by 
washing in 0.5% Tween 20/PBS. Fluorescein isothiocyanate (FITC)-conjugated 
streptavidin was then added (1:50 in 1% BSA/1 x PBS, Vector Laboratories, 
Peterborough, UK) at 4°C for 30 minutes, with samples covered in foil to protect 
them from direct light. A final wash in 0.5% Tween 20/1 x PBS was performed. 
Nuclear stain 4’,6-diamidino-2-phenylindole (DAPI, Vectashield, Vector 
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Laboratories, Peterborough, UK) was added to each well and a coverslip placed 
on top. Samples were viewed using a fluorescence microscope (Zeiss Axiovert 
200M, 10 x magnification, Fisher Scientific, Loughborough, UK). Staining intensity 
was calculated with Fiji software (Image J). Images were thresholded to minimise 
background noise. The threshold for each antibody was maintained for the 
assessment of all respective images. 
2.7 Actin ring staining 
Cells were cultured for 28 days. Medium was removed and cells were fixed with 
3.7% methanol-free formaldehyde (Sigma-Aldrich, Dorset, UK) for 10 minutes at 
room temperature in the dark. Samples were then washed twice with 1 x PBS and 
permeabilised with 0.1% Triton x-100. A further wash x 2 with 1 x PBS was 
performed. Rhodamine-Phalloidin (1:40 PBS, Thermo Fisher Scientific, 
Loughborough, UK) was added to sufficiently cover the cells prior to incubating in 
the dark at room temperature for 20 minutes. Samples were given a final wash x 
2 with 1 x PBS. Cover slips were applied and fluoroscopy images acquired using an 
EVOS® FL Auto 2 Cell Imaging System. 
2.8 Von Kossa staining 
Samples were cultured for 28 days. They were then fixed (4% formaldehyde/1 x 
PBS with 2% sucrose) at 37°C for 15 minutes. 5% silver nitrate was added to cover 
the cells before exposing to UV light for 30 minutes. Samples were then rinsed 
three times with deionised water. 5% sodium thiosulphate was then added for 10 
minutes to remove excess silver nitrate. They were then rinsed three times with 
deionised water. Counterstaining with 0.1% nuclear fast red for 10 minutes was 
then performed before a further rinse x 3 with deionised water. A final rinse with 
70% ethanol was performed. Digital images of the entire wells were acquired using 
an EVOS® FL Auto 2 Cell Imaging System. The percentage surface area stained was 
then calculated using Fiji software (Image J). 
2.9 Scanning electron microscopy 
Cells were fixed with buffered fixative (1.5% glutaraldehyde, 0.1 M sodium 
cacodylate) for 1 hour at 4°C. Samples were then rinsed with 0.1 M sodium 
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cacodylate for 3 x 5 minutes. Postfix in 1% osmium tetroxide for 1 hour at room 
temperature was then performed followed by 3 x 10 minutes wash with distilled 
water. A dehydration process was performed using an ethanol series (30, 50, 70 
and 90% for 5 minutes each x 2, followed by 100% for 5 minutes x 4, and dried 
absolute ethanol for 5 minutes x 4). Hexamethyl-disilazane (HMDS) was then 
applied to samples and left overnight for drying. An 18 nm gold palladium coating 
was overlaid on the sample surface using a Polaron SC515 SEM Coating System 
(Quorum Technologies, Sussex, UK). Finally, samples were attached to aluminium 
stubs and analysed on a Carl Zeiss Sigma variable-pressure analytical SEM (Carl 
Zeiss Ltd, Cambridge, UK). The accelerating voltage was 10 kV, with a working 
distance of 5 nm and 30 µm aperture.  
2.10 AlamarBlue assay 
Cell viability was assessed at defined time points using an alamarBlue assay 
(Thermo Fisher Scientific, Loughborough, UK) according to the manufacturer’s 
instructions. A 10% solution was produced (1 ml alamarBlue, 9 ml media). Media 
was removed from the wells and 500 µl of 10% alamarBlue added. Both the 
stimulated and control samples were then incubated at 37°C for 4 hours in the 
dark.  150 µl/well of 10% alamarBlue was then transferred in triplicate to a 96 
well plate. The remainder of 10% alamarBlue was discarded before washing three 
times with HEPES saline and adding fresh media. The absorbance was measured 
at 570 nm and 600 nm using a Multiskan FC Microplate Photometer (Thermo Fisher 
Scientific, Loughborough, UK). 
2.11 Live/dead stain 
An assessment of the proportion of live:dead cells in the 3D collagen gel was 
performed at defined time points. Media was first removed from the wells. A 
1:1000 dilution of ethidium homodimer and calcein AM (Thermo Fisher Scientific, 
Loughborough, UK) was made, and 400 µl added to each well. Plates were then 
incubated at 37°C for 45 minutes. The stain was then removed and 400 µl fresh 
warmed media added to the wells. The entire wells were then imaged with a 
fluorescent microscope (EVOS® FL Auto 2 Cell Imaging System) using both the 
green (470/22 nm excitation, 510/42 nm emission) and red (531/40 nm excitation, 
593/40 nm emission) filters.  
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2.12 RT-qPCR 
2.12.1 2D RNA extraction 
After culture for defined time points, media was removed from the samples and 
the wells gently washed with sterile 1 x PBS. They were then lysed using RLT buffer 
(QIAGEN, Manchester, UK). Lysates from wells were homogenised and then 
transferred to 1.5 ml nuclease free tube. RNA was extracted using RNeasy Micro 
Kit (QIAGEN, Manchester, UK) following the manufacturer’s instructions. 14 µl of 
RNase-free water was used to elute RNA. Nucleic acid quantification was 
performed using a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific, 
Loughborough, UK). Reading distilled water absorbance acted as a blank, and the 
samples were read at 260 nm to give quantification and the ratio of 260/280 used 
for purity estimation. RNA was then either immediately used for cDNA generation 
or stored at -80°C for later use.  
2.12.2  3D RNA extraction 
Attempts to employ the same technique for RNA extraction in 3D as 2D were 
unsuccessful. Measurement of RNA in the 3D cultures led to values so low that it 
was suspected the technique was inappropriate. Specifically, it was postulated 
that the collagen gels were blocking the RNeasy MinElute spin column membrane 
(QIAGEN, Manchester, UK) used to elute RNA. As an alternative to these spin 
columns a precipitation technique was employed, as described below. 
After culture for defined time points, media was removed before gently washing 
with sterile 1 x PBS. The gel was then disrupted with a pipette tip and transferred 
to an eppendorf. 350 µl TRIzol (Thermo Fisher Scientific, Loughborough, UK) was 
added and the tube vortexed to further disrupt the gel. Samples were incubated 
for 10 minutes to allow for cell lysis and subsequently centrifuged at 12000 x g for 
15 minutes at 4°C. The pellet was discarded and the RNA in solution transferred 
to a clean eppendorf. 100 µl chloroform was added before mixing vigorously for 
20 seconds then incubating at room temperature for 3 minutes. Samples were 
centrifuged at 12000 x g for 15 minutes at 4°C and the upper aqueous phase 
transferred to a clean tube. 1 µl glycoblue (Thermo Fisher Scientific, 
Loughborough, UK) was added to aid with visualisation of the pellet and 250 µl 
isopropanol (Sigma-Aldrich, Dorset, UK) mixed in to samples. The eppendorfs were 
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then incubated at -20°C for 1 hour and then centrifuged at 12000 x g for 15 
minutes at 4°C. The supernatant was discarded without disrupting the blue pellet. 
The RNA pellet was then washed twice with 70% ethanol and centrifuged 7500 x g 
for 5 minutes at 4°C. The ethanol was removed and the tube air-dried. The pellet 
was re-suspended in 20 µl RNase-free water and incubated at 60°C for 10 minutes 
to ensure full re-suspension.  Nucleic acid quantification was performed using a 
Nanodrop 1000 spectrophotometer. Reading distilled water absorbance acted as a 
blank, and the samples were read at 260 nm to give quantification and the ratio 
of 260/280 used for purity estimation. RNA was subsequently either immediately 
used for cDNA generation or stored at -80 °C for later use. 
2.12.3 cDNA generation 
100 – 300 ng of RNA was used to generate cDNA using QuantiTect Reverse 
Transcription Kit (QIAGEN, Manchester, UK) following the manufacturer’s 
instructions. RNA, RNase free water and gDNA Wipeout Buffer were combined to 
produce a volume of 14 µl and incubated for 2 minutes at 42°C. A master mix 
containing Quantiscript Reverse Transcriptase, Quantiscript RT buffer and RT 
Primer Mix was then produced, providing a total reaction volume of 20 µl. The 
samples were incubated at 42°C for 15 minutes and then 95°C for 3 minutes to 
terminate the reaction. cDNA was finally further diluted to a concentration of 5 
ng/µl and stored at -20°C. 
2.12.4 RT-qPCR 
Using a 96 well PCR plate, each sample was run in duplicate. A master mix was 
prepared using 10 µl SYBR Green (QIAGEN, Manchester, UK), 0.1 µl forward primer, 
0.1 µl reverse primer and 7.8 µl nuclease free water. This was added to each 
duplicate alongside 2 µl of cDNA, producing a volume of 20 µl per PCR well. The 
plate was then sealed using an adhesive PCR plate cover and centrifuged at 200 x 
g for 1 minute. Primers were provided by Eurofins (Eurofins, Hamburg, Germany) 
and the sequences shown in Table 2:1. An Abi7500 thermal cycler PCR machine 
(Thermo Fisher Scientific, Loughborough, UK) was used to run the samples. The 
primer sequences for the genes were validated by dissociation curve/melt curve 
analysis. The GapDH housekeeping gene primer/probe set was used (ABI 
predesigned amplification reagent) for normalisation. The ΔCT of each sample was 
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calculated with normalisation against GapDH. Blanks (no cDNA) were used to act 
as controls.  
Table 2:1 Forward and reverse primer sequences for RT-qPCR. 
Target Gene Forward Sequence Reverse Sequence 
ALP AGAACCCCAAAGGCTTCTTC CTTGGCTTTTCCTTCATGGT 
Cathepsin-K GCCAGACAACAGATTTCCATC CAGAGCAAAGCTCACCACAG 
IL-6 GATGAGTACAAAAGTCCTGATCCA CTGCAGCCACTGGTTCTGT 
M-CSF GAACTGCCAGTGTAGAGGGAAT GCTGGTCAGACAACATCTGG 
OSCAR CCAGCTCTAGCGGGTATCTG GACGGAGTGATGTCTGTGTGAC 
OPN AGCTGGATGACCAGAGTGCT TGAAATTCATGGCTGTGGAA 
OPG GAAGGGCGCTACCTTGAGAT GCAAACTGTATTTCGCTCTGG 
RANKL TGATTCATGTAGGAGAATTAAACAGG GATGTGCTGTGATCCAACGA 
TNF- α CAGCCTCTTCTCCTTCCTGAT GCCAGAGGGCTGATTAGAGA 
TRAP GGACTGAAGGGACTCCTGAAT GGTCCCTGAGCCTTTATTCC 
 
2.13 ELISA 
Cells were cultured for defined time periods, with regular media changes. The 
supernatant was removed and stored pending analysis at -80°C. The media was 
last changed 72 hours prior to removal for analysis.  96 well ELISA plates were 
prepared according to the manufacturer’s instructions (R&D Systems, Abingdon, 
UK). The capture antibody was diluted to the working concentration and 100 
µl/well added. The plates were sealed and left overnight at room temperature. 
Wells were then aspired and washed with 400 µl wash buffer (0.05% Tween 20 in 
1 x PBS) x 3. Plates were then blocked with 300 µl/well reagent diluent (1% BSA 
in 1 x PBS) for 1 hour. A further wash x 3 with wash buffer was performed. 100 
µl/well of either samples or standard was added, with duplicate technical 
replicates, and incubated at room temperature for 2 hours. A further wash x 3 was 
performed. 100 µl/well of detection antibody diluted in reagent diluent was added 
for 2 hours. A further wash x 3 was performed. 100 µl/well of Streptavidin-HRP 
was added for 20 minutes, avoiding direct light exposure. A further wash x 3 was 
performed. 100 µl/well of substrate solution (1:1 mixture of Colour Reagent A and 
B) was added for 20 minutes, avoiding direct light exposure. Finally, 50 µl/well of 
Stop Solution was added. The optical density was calculated at 450 nm using a 
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Multiskan FC Microplate Photometer. A standard curve was created with Prism v6 
(GraphPad Software, California, USA) and the results interpolated from this.  
2.14 Osteoclast functional assessment  
The Osteo Assay Surface is a multiple well plate. The base of each well is coated 
with a synthetic inorganic bone surface. As osteoclasts resorb this surface coating, 
the plate can be used to determine the function of osteoclasts by measuring the 
area resorbed. CD14+ cells were selected as per the technique described above. 
Cells were then seeded at a concentration of 1 x 106 /ml onto a 24 well Osteo 
Assay Surface plate (Corning, Flintshire, UK). The RANKL was added at a 
concentration of 25 ng/ml after approximately 18 hours incubation. Media was 
refreshed twice weekly. After 7 days incubation, the cell layer was removed by 
adding 10% chlorine solution (Sigma-Aldrich, Dorset, UK) to the wells at room 
temperature for 10 minutes. The wells were examined to ensure all cells had been 
removed before rinsing thoroughly with deionised water and leaving to dry. Images 
were then captured using an EVOS® FL Auto Cell Imaging System and the area of 
resorption calculated using Fiji software (Image J). 
2.15 Metabolomics 
Cells were cultured for defined time periods. All the media was removed from the 
wells and then gently washed with 1 x PBS at 4°C. All the PBS was removed before 
adding 500 µl/well of chilled extraction solvent (1:3:1 chloroform: methanol: 
water). Solvent was also placed in a well without cells to produce a blank. Plates 
were then sealed with parafilm and vigorously agitated on a rotary shaker for 1 
hour at 4°C. The solvent was removed from the wells and placed in an eppendorf 
before centrifuging at 1300 rpm for 3 minutes. The supernatant was removed and 
placed in a new eppendorf. 50 µl of each sample was placed in a separate tube to 
produce a pooled sample of each condition. Samples were stored at -80°C pending 
transfer to the Glasgow Polyomics department.  
2.15.1 Liquid chromatography-mass spectrometry  
This stage of the experiment was conducted by the staff of the Glasgow Polyomics 
department. This technique involves separation of the components of the mixture 
based on chemical properties, before quantifying the mass of the varying analytes 
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based on their mass: charge ratio (Clish CB, 2015). Utilising standards of known 
metabolites then helps identify the specific constituents. The Glasgow Polyomics 
department used the UltiMate 3000 RSLC and Orbitrap Q-Exactive (Thermo Fisher 
Scientific, Loughborough, UK). 
2.15.2 Data analysis  
The data produced by LC-MS was converted to an IDEOM file by the Polyomics 
staff. This Excel file details the varying metabolites identified and their respective 
quantities. Furthermore, the metabolites are linked to the KEGG database (Kyoto 
Encyclopaedia of Genes and Genomes) which facilitates examination of varying 
chemicals and biological pathways (Fiehn O, 2002). The files were generated 
containing the metabolite KEGG IDs and their ratio to the specified control. These 
files were analysed with IPA (Ingenuity Pathway Analysis); a programme that 
identifies and predicts alterations in pathways and networks. 
 
2.16 Statistical analysis 
The appropriate statistical analyses were preformed using GraphPad Prism 
software (version 6).  Normally distributed data were analysed with the t-test. 
Conversely, if the data were not normally distributed the Mann-Whitney U test 
was utilised. Statistically significant results were defined as those having a p value 
of 0.05 or less. 
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 Nanoscale vibration of CD14+ culture 
3.1 Introduction 
The primary aims of this project are to examine the effects of nanoscale vibration 
on 1) osteoclasts, and 2) a co-culture of MSCs and BMHCs. The results of 
osteoclasts will first be discussed. Osteoclasts were obtained by selection CD14+ 
cells from blood, as discussed in Chapter 2.2. Within this culture, there were two 
main cell types – macrophages and osteoclasts. As osteoclasts would only form in 
the presence of RANKL (Zhang S et al, 2017), the production of two different 
conditions was established: 1) an M-CSF group, where only macrophages would be 
present, and 2) an M-CSF + RANKL group, containing osteoclasts, pre-osteoclasts 
and macrophages. It was beneficial to have a relatively pure culture of 
macrophages and osteoclasts for investigation in addition to the co-culture, as this 
allowed an assessment of the effects on nanoscale vibration without the influence 
of MSCs. 
In addition to assessing the impact of nanoscale vibration on these cell cultures, 
it was equally important to measure the nanoscale displacements themselves. This 
was to ensure the bioreactor was correctly calibrated and would produce the 
correct displacements using a 24 well plate. Thermal imaging and shear flow 
measurements were not undertaken as this work has already been carried out by 
other authors, demonstrating no significant heat transference to the cell culture 
or production of fluid shear stress (Tsimbouri PM et al, 2017b, Nikukar H et al, 
2016).  
3.2 Materials and methods 
Experiments were conducted as laid out in the Materials and Methods chapter. 
Cells were cultured using standard laboratory techniques, including sterile 
working conditions, laminar flow cabinets and incubators at 37°C with 5% CO2. 
Cell numbers were kept standard across all experiments as were frequency of 
media changes and volume of media used (2 ml/well for 2D culture, 1 ml/well for 
3D). Maintaining the same volume ensured the vertical pressure of the media on 
the cells was comparable throughout. 24 well plates were used for all 
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experiments. Following seeding of cells, plates were left for 4 hours to allow cells 
to settle on the cultureware surface prior to placing on the Nanokick bioreactor.  
The initial attempts to differentiate osteoclasts proved unsuccessful. Macrophages 
were present however there was no evidence of fusion despite the addition of 
RANKL. Following a number of changes, including cell count and well size, it was 
found that the batch of FBS used was not conducive to osteoclast differentiation. 
Although no changes to manufacturer were made, once a new batch was used 
osteoclasts were successfully produced. Going forward, this batch was stored and 
used. When depleted, small experiments were conducted to ensure any new batch 
of FBS facilitated osteoclast formation prior to larger experiments being 
established.  
A number of time points were used for different experiments. These included days 
1, 2, 3, 5 and 7. With the addition of RANKL to the culture, osteoclasts were 
present from around day 3 onwards – a finding consistent with other papers in the 
literature (Marino S et al, 2014) – and were mature by day 7. Extended cultures 
beyond day 7 was not felt to be beneficial for this reason. 
3.3 Results  
3.3.1 Bioreactor calibration  
As each bioreactor can accommodate 2 x 24 well plates, 48 separate displacement 
measurements were taken (Figures 3:1 and 3:2). The set-up of the laser 
interferometer and bioreactor is illustrated in the Materials and Methods chapter. 
The mean displacement was found to be 40.6 nm (Table 3:1). Measurement of the 
bioreactor was undertaken periodically to ensure no change in displacement had 
occurred.  
There were no significant peaks or troughs in vertical displacement identified 
across the bioreactor surface. Previous ANSYS finite element modelling had 
suggested the corners of the bioreactor would potentially produce higher 
displacements (Figure 1:6) but this was not found to be the case in any of the 
calibrations. This could potentially be attributed to evolution of the Nanokick 
bioreactor design from the 1st to the 3rd generation.  
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Figure 3:1 Measurement of vertical displacements with laser interferometry. 
The Nanokick bioreactor is placed on an anti-vibration table to minimise background interference. 
Magnetic sheets are fixed to the 24 well plate to facilitate attachment of cultureware onto the 
bioreactor. Prismatic tape is placed in the base of each well to reflect the laser and measure vertical 
displacements, as detailed in Chapter 2.4.  
 
Figure 3:2 Interferometry measurement locations on Nanokick bioreactor. 
Each bioreactor has space for two standard culture plates. Each number (1 – 48) corresponds to a 
single well of a 24 well plate where a laser interferometry measurement was taken. Values 1-24 and 
25 – 48 represent to the two plate locations. The power input cable is depicted at the bottom right of 
the bioreactor.  
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Table 3:1 Vertical displacement measurements for the Nanokick bioreactor. 
48 well positions were measured, as depicted in the figure above. The mean vertical displacement 
was 40.6 nm (SD 9.8 nm). Although there was variation between wells none were felt to be 
significantly different. 
Well Vertical displacement (nm) Well Vertical displacement (nm) 
1 44 13 46 
2 69 14 31 
3 45 15 26 
4 31 16 32 
5 33 17 39 
6 39 18 41 
7 74 19 40 
8 50 20 30 
9 30 21 39 
10 29 22 40 
11 36 23 40 
12 40 24 42 
 
Well Vertical displacement (nm) Well Vertical displacement (nm) 
25 33 37 45 
26 34 38 45 
27 28 39 42 
28 24 40 39 
29 37 41 51 
30 41 42 50 
31 34 43 46 
32 29 44 43 
33 39 45 57 
34 42 46 53 
35 38 47 49 
36 37 48 47 
 
3.3.2 Osteoclast differentiation  
As previously noted, osteoclasts stain intensely for TRAP. Other cell types 
including macrophages and dendritic cells also stain for TRAP, however. To 
differentiate between osteoclasts and the other cell types, they were identified 
as those that were TRAP positive with three or more nuclei. This allowed 
measurement of cell number and area to be performed. This experiment was a 
useful starting point as it allowed a quick determination on whether osteoclasts 
Chapter 3 Nanoscale vibration of CD14+ culture 54 
were formed and an objective assessment of morphological change between 
groups.  
The results shown below are only for the samples with RANKL added. Those with 
only M-CSF did not show evidence of osteoclast differentiation as expected. In the 
nanokick group, a significant reduction in the number of osteoclasts per well was 
found (Figure 3:3, p=0.034). Similarly, a significant reduction in mean osteoclast 
area was found in the nanokick group (Figure 3:4, p<0.001). The cell count and 
area were reduced by approximately 32% and 34%, respectively. Figure 3:5 
illustrates a typical TRAP stain image. 
 
Figure 3:3 Osteoclast cell count.  
A significant reduction in osteoclast numbers was observed in the nanokick group following 7 days 
of culture. One donor was found to have a viably lower number of osteoclasts present, as can be 
seen in the data plots above. However, in this donor there was still a reduction in cell numbers in the 
nanokick group. Graph shows mean +/- SD. * = p<0.05, by Mann-Whitney U test. N=3 cell donors. 
 
Figure 3:4 Osteoclast area measurement.  
A significant reduction in osteoclast area was demonstrated in the nanokick group. As the data points 
illustrate, there is a potentially wide variation in the cell size observed within each culture.  Graph 
shows mean +/- SD. *** = p<0.001, by t-test. N=3 cell donors. 
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Figure 3:5 TRAP stained CD14+ culture image. 
10 x magnification brightfield microscopy image. This image demonstrates numerous osteoclasts 
(those cells with three or more nuclei) surrounded by smaller macrophages following 7 days of culture 
with RANKL. This figure illustrates the potentially variable osteoclast cell size that can be present 
within a culture, as also noted in Figure 3:4.  
3.3.3 AlamarBlue cell viability assessment  
TRAP staining demonstrated a reduction in osteoclast numbers. Moving forward, 
cell viability was assessed to determine whether this reduction could be attributed 
to lower cell metabolism or viability. This was performed for the +RANKL culture 
given osteoclasts were the cell of interest that had demonstrated an effect 
following nanoscale vibration. The alamarBlue cell viability reagent assay was 
therefore performed. This assay quantifies cell viability by measuring their ability 
to reduce resazurin to resorufin (Back SA et al, 1999). A significant increase in the 
percentage of alamarBlue reduced was found in the nanokick group at day 3 
(Figure 3:6, p=0.003). This suggests increased cell viability in the nanokick group 
at this stage. By day 7, there was no difference between the two groups.  
100 µm 
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Figure 3:6 alamarBlue cell viability reagent assay of CD14+ culture.  
A significant increase in percentage alamarBlue reduction was observed in the nanokick group at 
day 3. No difference was found at day 7. This suggests increased cell death was not the cause of 
the reduction in osteoclast numbers observed in the nanokick group. Graph shows mean +/- SD. ** 
= p<0.01, by t-test. N=3 cell donors. 
3.3.4 Scanning electron microscopy 
TRAP staining had demonstrated a reduction in osteoclast numbers and area. To 
gain further insight into other potential morphological changes, scanning electron 
microscopy (SEM) was undertaken. This facilitated more detailed examination of 
the cells structure. Three main cell types were identified: macrophages, 
osteoclasts precursors and osteoclasts. Osteoclast precursors were less spherical 
in appearance than macrophages, but lacked the size of osteoclasts. It is likely 
these cells are in the early stages of fusion. There were no obvious changes in 
appearance between the control and nanokick group, however. Subjectively, a 
lower density of osteoclasts was observed in the nanokick group, conforming with 
the TRAP stain data, but those cells which were present did not display differing 
features. Macrophages were frequently seen in clusters around larger osteoclasts, 
potentially indicating they were in the stage prior to fusion.  
Osteoclasts demonstrated the typical filopodia seen in this cell type. Filopodia 
were observed on the periphery of the osteoclasts, which are known to play a role 
in cell-cell fusion (Song RL et al, 2014). Phagocytotic pits were also observed in 
mature osteoclasts; a feature noted by other authors (Young PS et al, 2015) (Figure 
3:7).  
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Figure 3:7 SEM images of CD14+ culture.  
A and B show macrophages. C and D: osteoclast precursors appear less spherical than 
macrophages, but are smaller than mature osteoclasts. E and F: lower magnification images showing 
multiple osteoclasts surrounded by the smaller, more spherical macrophages. Arrow indicates 
phagocytosis pit. Note the lower density of osteoclasts observed in the nanokick group. 
3.3.5 Osteoclast functional analysis  
The initial experimental results had demonstrated a reduction in osteoclasts 
numbers. While this is significant, potentially of more importance is the 
functionality of the osteoclasts. Specifically, their ability to resorb bone. Cells 
were seeded onto the Osteo Assay surface plate and the area of collagen resorbed 
measured. A significant reduction in surface area resorbed at day 7 was observed 
in the nanokick group (Figure 3:8, p=0.04). This result refers only to the +RANKL 
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group; as expected there was no resorption demonstrated in the M-CSF group 
where only macrophages would be present (Figure 3:9).  
 
Figure 3:8 Osteoclast-mediated resorption of Osteo Assay surface plate. 
Measurement of percentage surface area resorbed was performed. A significant reduction (p=0.04) 
was found in the nanokick group 7 days following seeding of the CD14+ culture with RANKL added. 
This result is not surprising given the lower number of osteoclasts observed, but is important as it 
indicates there is no increase in activity. Graph shows mean +/- SD. * = p<0.05, by t-test. N=3 cell 
donors. 
 
 
Figure 3:9 Images of Osteo Assay surface demonstrating osteoclast-mediated resorption. 
2 x magnification brightfield microscopy images of entire well of a 24 well Osteo Assay surface plate. 
Image A shows no resorption has taken place in the M-CSF group. The lighter coloured areas present 
in image B illustrate where osteoclasts have resorbed the collagen surface coating.  
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3.3.6 Cell viability in 3D collagen gel 
To ensure the CD14+ culture was viable in the collagen gel for progression to 3D 
models, a live/dead stain was performed, using the methodology set out in 
Chapter 2.11. This demonstrated >99% living cells present in the culture after 7 
days incubation (Figure 3:10). This therefore confirmed the 3D technique was able 
to support this cell culture.  
 
Figure 3:10 Live-dead stain microscopy images of 3D CD14+ culture. 
A – 2 x magnification image of entire well in 24 well plate. Cells stained green are living. Conversely 
red cells are dead. This highlights >99% living cells utilising the collagen gel model after 7 days, 
which represent the longest time point in the CD14+ culture. B – 10 x magnification image of M-CSF 
group, illustrating macrophages seeded throughout the gel. C – 10 x magnification of +RANKL group. 
The large cell in the centre of the image is consistent in appearance with an osteoclast, suggesting 
fusion of macrophages to form osteoclasts occurs in the collagen gel. 
3.3.7 Gene expression  
RNA was extracted using the techniques detailed in Chapter 2.12 (with different 
approaches for 2D and 3D) and subsequently used for cDNA synthesis and qPCR. 
GapDH was used as the housekeeping gene. Osteoclast stimulatory (TRAP, OSCAR, 
cathepsin-K, IL6, RANKL and TNF-α), macrophage stimulatory (M-CSF) and 
osteoclast inhibitory genes (OPG) were assessed.  
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3.3.7.1 2D M-CSF group 
Four time points were assessed: days 1, 2, 3 and 7. Across these stages, there 
was a general trend towards increases in osteoclast stimulatory genes in the 
nanokick group (Figure 3:11). However, there were only two statistically 
significant results: an increase in cathepsin-K and day 1 (Figure 3:12) and an 
increase in OPG (Figure 3:13) at day 7. This paints a conflicting picture given 
that cathepsin-K is a pro-osteoclast gene, whilst OPG inhibits osteoclast 
differentiation. The heatmaps below demonstrate the trends observed. The 
statistically significant results are illustrated in greater detail through the 
corresponding Figures.  
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Figure 3:11 RT-qPCR heatmaps of 2D M-CSF group. 
The M-CSF group comprises macrophages only, as osteoclast differentiation requires the addition 
of RANKL. The general trend that can be observed is an increase in osteoclast stimulatory genes in 
the nanokick group. Significant increases in both cathepsin-K and OPG were observed in the 
nanokick group. 
 
Figure 3:12 Cathepsin-K RT-qPCR result of 2D M-CSF group at day 1. 
A significant increase in cathepsin-K expression – a pro-osteoclast gene – was found in the nanokick 
group. Cathepsin-K is an enzyme release by osteoclasts to promote bone resorption and so would 
not be secreted by this culture of isolated macrophages. However, it suggests nanoscale vibration 
may be priming macrophages for bone resorption. Graph shows mean +/- SD. * = p<0.05, by t-test. 
N=3 cell donors. 
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Figure 3:13 OPG RT-qPCR result of 2D M-CSF group at day 7. 
A significant increase in the osteoclast inhibitory gene OPG was found in the nanokick group at this 
time point. OPG inhibits the differentiation and function of osteoclasts (Udagawa N et al, 2000). 
Graph shows mean +/- SD. ** = p<0.01, by t-test. N=1 cell donor. 
3.3.7.2 2D +RANKL group 
The +RANKL group comprised a culture of osteoclasts and macrophages. There was 
a significant increase in cathepsin-K at day 1 in the nanokick group (Figure 3:15). 
However, in subsequent time points there was a non-significant reduction in this 
gene in the nanokick group. Similarly, the pro-osteoclast genes TNF-α, M-CSF and 
IL-6 were reduced at day 3, although the difference did not reach statistical 
significance. OSCAR, M-CSF and TNF-α had a similar non-significant reduction at 
day 7 in the nanokick group. These trends are highlighted in Figure 3:14.
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Figure 3:14 RT-qPCR heatmaps of 2D +RANKL group. 
The only significant difference identified was an increase in cathepsin-K at day 1 in the nanokick 
group. A non-significant reduction was subsequently observed at all future time points. Although 
reductions in certain pro-inflammatory and osteoclast-stimulatory genes were found in the nanokick 
group, the differences in gene expression were largely subtle at all time points.  
 
Figure 3:15 Cathepsin-K RT-qPCR result of 2D +RANKL group at day 1. 
Similar to the M-CSF group, cathepsin-K expression was found to be significantly increased in the 
nanokick group. As noted above, this enzyme promotes bone resorption. Interestingly, there was a 
non-significant reduction in the expression of cathepsin-K in the nanokick group at subsequent time 
points. Graph shows mean +/- SD. * = p<0.05, by t-test. N=4 cell donors. 
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3.3.7.3 3D M-CSF group 
The same 4 time points were assessed in 3D as in 2D (Figure 3:16). In this culture, 
a significant decrease in cathepsin-K (Figure 3:17), M-CSF (Figure 3:18) and TNF-
α (Figure 3:19) was observed in the nanokick group. This suggests lower levels of 
inflammation and osteoclast stimulatory genes were present following exposure 
to nanoscale vibration. Again, it is interesting that cathepsin-K levels were found 
to be significantly different given that this enzyme is produced by osteoclasts and 
the M-CSF group only contains macrophages.  
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Figure 3:16 RT-qPCR heatmaps of 3D M-CSF group. 
Although there were three different significantly different genes identified, it is difficult to discern the 
overall trend in this experimental condition. Most genes were elevated in the nanokick group at day 
1. In the remaining time points, there was a fairly even split of upregulation and downregulation 
between the groups.  
 
Figure 3:17 Cathepsin-K RT-qPCR result of 3D M-CSF group at day 2. 
A significant reduction in the pro-osteoclast gene was observed in the nanokick group. This differs 
from the result obtained in the 2D culture, where cathepsin-K was significantly increased at day 1, 
and a nonsignificant increased observed at day 2. Graph shows mean +/- SD. * = p<0.05, by t-test. 
N=1 cell donor. 
C
on
tr
ol
N
an
ok
ic
k
0.0
0.5
1.0
1.5
2-ΔΔCT *
Chapter 3 Nanoscale vibration of CD14+ culture 66 
 
Figure 3:18 M-CSF RT-qPCR result of 3D M-CSF group at day 2. 
A significant reduction in M-CSF expression was found in the nanokick group. This suggests 
nanoscale vibration may inhibit proliferation of macrophages in 3D conditions. Graph shows mean 
+/- SD. ** = p<0.01, by t-test. N=1 cell donor. 
 
Figure 3:19 TNF-α RT-qPCR result of 3D M-CSF group at day 3. 
A significant reduction in the expression of pro-inflammatory gene TNF-α was exhibited in the 
nanokick group. TNF-α has multiple functions including initiating and perpetuating inflammation, 
prolonging macrophage survival and inducing osteoclast formation (Parameswaran N and Patial S, 
2010). Graph shows mean +/- SD. * = p<0.05, by t-test. N=4 cell donors.  
3.3.7.4 3D +RANKL group 
Similar to the M-CSF group, differences in gene expression trends were not 
consistent. There was potentially a trend towards increases in osteoclast 
stimulatory genes in the nanokick group, but changes were subtle (Figure 3:20). 
OSCAR was elevated at day 3 (Figure 3:21), but reduced at all other time points. 
Many of the genes were upregulated in the nanokick group at the early time points, 
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but subsequently downregulated by day 7, suggesting nanoscale vibration may 
induce gene level changes early in the differentiation stage. 
 
 
Figure 3:20 RT-qPCR heatmaps of 3D +RANKL group. 
Many of the genes were found to be upregulated in the nanokick group at days 1 – 3. However, by 
day 7, all were reduced. OSCAR was significantly elevated at day 3, but reduced in all other time 
points.  
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Figure 3:21 OSCAR RT-qPCR result of 3D +RANKL group at day 3. 
A significant increase in the expression pro-osteoclast gene OSCAR was observed in the nanokick 
group. OSCAR plays an important role in osteoclast differentiation (Nemeth K et al, 2011). Graph 
shows mean +/- SD. ** = p<0.01, by t-test. N=4 cell donors.  
3.3.8 Protein assay 
Similar to the RT-qPCR experiments, ELISA was performed for both the M-CSF and 
RANKL groups in both 2D and 3D and days 3 and 7. Osteoclast stimulatory (IL-6 and 
TNF-α) and inhibitory (OPG) proteins were quantified. This was performed given 
the ambiguity of the RT-qPCR results. Furthermore, gene level changes detected 
through RT-qPCR may not result in alterations in protein levels and so performing 
ELISA was a useful next step. 
3.3.8.1 2D M-CSF 
At day 3, a significant reduction in OPG was found in the nanokick group. This 
contrasted with the day 7 RT-qPCR result as OPG was elevated in the nanokick 
group. Although OPG is an inhibitor of osteoclastogenesis (Boyce BF and Xing L, 
2008) there were no osteoclasts present in these cultures. Macrophages have been 
shown to be a source of inflammatory cytokine IL-1 when under the influence of 
elevated OPG, leading to more invasive breast tumours in cancer models (Chung 
ST et al, 2017). It is therefore challenging to interpret the ultimate outcome of 
OPG in this culture condition. There was no significant difference at day 7 (Figure 
3:22). 
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Figure 3:22 ELISA results for 2D M-CSF group. 
A significant reduction in OPG was found in the nanokick group at day 3 (86.5 cf 82.9 pg/ml). No 
difference was present at day 7. Graph shows mean +/- SD. * = p<0.05, by t-test. N=3 cell donors. 
3.3.8.2 2D +RANKL 
A significant reduction in pro-inflammatory cytokine IL-6 was demonstrated in the 
nanokick group at day 3. IL-6 has been shown to promote osteoclastogenesis (Wu 
Q et al, 2017) and so the lower levels observed tie in with the reduction in 
osteoclast numbers observed. By day 7, however, there was no significant 
difference (Figure 3:23). 
 
Figure 3:23 ELISA results for 2D +RANKL group. 
A significant reduction in pro-inflammatory cytokine IL-6 was observed in the nanokick group at day 
3 (25.7 cf 24.1). No significant differences were found at day 7. Graph shows mean +/- SD. * = 
p<0.05, by t-test. N=3 cell donors. 
3.3.8.3 3D M-CSF 
Similar to the 2D M-CSF group, reductions in OPG were observed in the nanokick 
group at both day 3 and 7 (Figure 3:24). As noted, the role of OPG in macrophages 
is multimodal, with both inhibition of osteoclastogenesis and promotion of IL-1 
secretion.  
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Figure 3:24 ELISA results for 3D M-CSF group. 
A significant reduction in OPG was found in the nanokick group at day 3 (150.6 cf 144.8) and day 7 
(108.6 cf 105). Graph shows mean +/- SD. ** = p<0.01, by t-test. N=3 cell donors. 
3.3.8.4 3D +RANKL 
The trend towards a reduction in OPG continued in the +RANKL group at day 7 
(Figure 3:25). As noted in Chapter 1.8, OPG has been shown to be produced by 
osteoclasts as part of a self-regulatory function when MSCs are not present (Kang 
JH et al, 2014). It is possible the lower number of osteoclasts present in the 
nanokick group has led to lower levels of OPG being secreted through this auto-
regulatory mechanism. It should be noted that in all the experimental conditions, 
the absolute differences in protein concentrations were relatively small and so 
this must be borne in mind when interpreting the significance of the results 
observed. 
 
Figure 3:25 ELISA results for 3D +RANKL group. 
A significant reduction in OPG was observed in the nanokick group at day 7 (113.3 cf 105.8). Graph 
shows mean +/- SD. * = p<0.05, by t-test. N=3 cell donors. 
3.3.9 Metabolomics  
Metabolomics refers to the comprehensive identification and quantification of 
metabolites in a biological specimen (Clish CB, 2015). It has the benefit of being 
highly sensitive and unbiased. Metabolites are the end product of cellular 
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processes and as such can be viewed as a marker of genetic and environmental 
change in that biological system (Fiehn O, 2002). Recent research has 
demonstrated metabolomics can be utilised to investigated stem cell responses to 
topographical changes (McNamara LE et al, 2012). Stem cells have been found to 
be metabolically inactive when compared to the increased metabolic activity 
observed in actively differentiating cells. Metabolome analysis can therefore 
provide a snap shot in to biological activity and phenotype (Tsimbouri PM et al, 
2012). Given the large quantity of data produced, which has been cited as a 
potential issue with this field (Daviss B, 2005), it is beneficial to focus on pathways 
and networks relevant to the area of research. 
3.3.9.1 M-CSF group 
The M-CSF group was cultured for three days before metabolite extraction was 
performed. The results presented are the main pathways and top scoring networks 
identified on IPA, using the methodology presented in Chapter 2.15.2. Pathways 
related to amino acid synthesis were found to have the greatest reduction in Z-
scores (i.e. standard deviations away from the mean) in the nanokick group. 
Specifically, tRNA charging, arginine and lysine had reductions in Z-scores in the 
nanokick group (Figure 3:26). tRNA is responsible for amino transport (Lodish H et 
al, 2000), and high levels of amino acid synthesis are associated with self-renewal, 
differentiation and proliferation (Zhao T et al, 2012, Sampath P et al, 2008).  
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Figure 3:26 Pathway analysis of M-CSF group. 
Metabolite analysis with IPA identified a number of changes between the control and nanokick group. 
The greatest changes identified were reductions in tRNA and amino acid degradation in the nanokick 
group. Sirtuin was found to be increased, which acts to inhibit macrophage driven inflammation (Liu 
P et al, 2018). The threshold for significance is p <0.05 with Fisher’s exact test. N=3 cell donors.  
Examination of the top scoring networks predicted inhibition of several key 
complexes in the nanokick group, including IL-1, TNF, NF-κB, JNK and pro-
inflammatory cytokine. JNK is an important factor in osteoclast survival, and NF-
κB is essential for the osteoclastic action of RANKL (Ikeda F et al, 2008). When 
pathways for IL-6 and role of osteoblasts, osteoclasts and chondrocytes in 
rheumatoid arthritis were included in the network, almost every complex was 
found to be inhibited (Figure 6:1). This is of interest given the reduction in TNF-α 
and IL-6 found with RT-qPCR and ELISA, respectively. ALP – an osteogenic marker 
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– was the only upregulated complex. Table 3:2 highlights the key complexes that 
were altered. The full network analysis is presented in the Appendices.  
Table 3:2 Selected complexes activated and inhibited in metabolomics network analysis of 
nanokick M-CSF group 
Inhibition  Activation  
HIF1 ALP 
NF-κB LDL 
JNK 
IFN-ϒ 
IL-1 
TNF 
Pro-inflammatory cytokine 
C/EBP 
PARP 
  
3.3.9.2 +RANKL group 
The +RANKL samples were also cultured for three days prior to metabolite 
extraction. Analysing the top scoring networks and pathways revealed some 
similarities with the M-CSF group. The greatest reductions in Z-score were found 
for tRNA charging and amino acid metabolism in the nanokick group (Figure 3:28). 
As noted above, amino acids are crucial for self-renewal, differentiation and 
proliferation. Citrulline was one of the most significantly inhibited amino acids. 
This amino acid, which can be synthesised from arginine (also inhibited), has been 
implicated in osteoclast differentiation and bone resorption in rheumatoid 
arthritis (Harre U et al, 2012). The amino acid serine was also inhibited, which is 
required for NFAT2 induction by RANKL and, therefore, plays a role in upregulating 
osteoclastogenesis (Ogawa T et al, 2006, Pollari S et al, 2011). 
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Figure 3:27 Pathway analysis of +RANKL group. 
Metabolite analysis with IPA identified a number of changes between the control and nanokick group. 
The significant changes were similar to those identified in the M-CSF group, namely reductions in 
tRNA and amino acid metabolism in the nanokick group. The threshold for significance is p <0.05 
with Fisher’s exact test. N=3 cell donors.  
On analysis of the top scoring networks, an inhibition of several pro-inflammatory 
and osteoclast stimulatory markers was predicted. These include TNF, NF-κB, pro-
inflammatory cytokine, poly ADP ribose polymerase (PARP) and nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase. PARP stimulates 
osteoclastogenesis (Beranger GE et al, 2006) and NADPH oxidase has been show to 
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promote osteoclast differentiation by stimulating NFATc1, a downstream factor of 
RANKL (Kang IS and Kim C, 2016). Phospholipase A2 (PLA2) was also reduced. 
Inhibition of PLA2 in vitro has been shown to suppress osteoclastogenesis (Allard-
Chamard H et al, 2014). Sirtuin 6 (SIRT6) was increased, which has been shown to 
inhibit osteoclastogenesis by inhibiting NF-κB (Zhang D et al, 2018). Adenosine 
monophosphate-activated protein kinase (AMPK) was similarly increased, which 
although promotes the survival of osteoblasts, negatively impacts osteoclast 
differentiation by suppressing RANKL (Lee YS et al, 2010). Conversely, low density 
lipoprotein (LDL) and aryl hydrocarbon receptor (AhR) were increased, both of 
which have been shown to promote osteoclast survival (Luegmayr E et al, 2004, 
Izawa T et al, 2016). When the canonical pathways for IL-6 and roles of 
osteoblasts, osteoclasts and chondrocytes in rheumatoid arthritis were overlaid 
on to the network, the majority of complexes were inhibited. As with the M-CSF 
group, the osteogenic marker ALP remained elevated (Figure 6:2). Table 3:3 
highlights the key complexes that were altered. The full network analysis is 
presented in the Appendices. 
Table 3:3 Selected complexes activated and inhibited in metabolomics network analysis for 
nanokick +RANKL group 
Inhibition  Activation  
HIF1 ALP 
NF-κB LDL 
NADPH SIRT6 
PLA2 AMPK 
IL-1 AhR 
TNF 
Pro-inflammatory cytokine 
C/EBP 
PARP 
 
3.4 Discussion 
In this chapter we examined the effects of nanoscale vibration on a culture of 
macrophages and osteoclasts. No other studies thus far have done so. It is 
necessary to assess the response of osteoclasts to nanoscale vibration when 
attempting to produce tissue engineered bone given their close interaction with 
osteoblasts (Chen X et al, 2018). Doing so first in insolation – i.e. not in a co-
culture alongside MSCs and osteoblasts – enabled a true portrayal of their response 
to vibration. 
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Nanoscale vibration was produced by the Nanokick bioreactor, with vertical 
displacements in the order of 40 nm at 1000 Hz. This stimulation resulted in a 
reduction in the number of osteoclasts produced.  The reduction was 
approximately 30% in all donors. It was interesting that this inhibition of osteoclast 
formation was relatively uniform across all the donors as this suggests the effect 
of vibration is constant irrespective of patient-to-patient variation. The 
osteoclasts were not just fewer in number, but also smaller in size. This confirmed 
that the reduction in number was not due to their fusion into larger cells. Given 
the same number of cells were seeded in both the control and nanokick groups, 
this suggests more macrophages and osteoclast progenitors (i.e. cells with less 
than 3 nuclei) would be present in the nanokick group. Other authors have found 
a similar pattern, demonstrating a reduction in osteoclast numbers when exposed 
to mechanical stimulation (Kameyama S et al, 2013, Kulkarni RN et al, 2013). 
Although not utilising nanoscale vibration or human cells, these studies do lend 
support to the results observed.  
SEM was used to analyse the appearance of the osteoclasts in more detail. Similar 
cell types were observed in both the control and nanokick groups, namely 
macrophages, osteoclast precursors and osteoclasts.  Filopodia and phagocytotic 
pits were present; these features are important for cell migration and bone 
resorption and their presence infers mature osteoclastogenesis was achieved in 
both groups (Young PS et al, 2015, Song RL et al, 2014). Subjectively, however, a 
lower density of osteoclasts was observed in the nanokick group. Given the lower 
cell number of osteoclasts observed, alamarBlue assay was performed to 
determine whether increased cell death could be responsible. An increase in cell 
metabolic activity and viability was found in the nanokick group at day 3, 
indicating increased cell death was not the cause of the disparity. This result made 
inhibition of osteoclast differentiation and maturation a more likely hypothesis. 
The primary function of osteoclasts is to break down bone (Kim JH and Kim N, 
2016). The ability of the cells in this culture to resorb a collagen-coated surface 
was therefore tested. A significant reduction in osteoclast-mediation resorption 
was observed in the nanokick group at day 7. This could be considered more 
significant than purely the number of osteoclasts present, as a small number of 
highly “aggressive” osteoclasts would be detrimental to new bone formation and 
graft production.  Importantly, however, osteoclast function was not completely 
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impaired. Normal bone remodelling relies upon the coordinated action of 
osteoblasts and osteoclasts, and without the presence of the later abnormal bone 
would form, as in osteopetrosis (Chen X et al, 2018). 
RT-qPCR was undertaken with the aim of providing an insight into the underlying 
mechanism behind the lower osteoclast number and resorption ability.  
Unfortunately, no clear picture emerged from this. Varying time points in both 2D 
and 3D showed increases and decreases in osteoclast stimulatory and inhibitory 
genes. It is therefore difficult to determine what gene changes are of significance 
to the morphological changes observed. It is possible that the primary genes 
responsible were not tested in this study. A broad range of primers was utilised, 
with both osteoclast stimulatory and inhibitory roles, in an effort to capture the 
underlying mechanism. It was not exhaustive, however, and so in an effort to gain 
greater clarity, ELISA was performed to examine for potentially significant 
changes in protein production. This result was again slightly conflicting. IL-6 – an 
osteoclast stimulatory cytokine (Wu Q et al, 2017) – was found to be significantly 
reduced in the nanokick group. Conversely, OPG – an inhibitor of 
osteoclastogenesis (Boyce BF and Xing L, 2008) – was also reduced. The cause for 
this reduction is not clear given the lower number of osteoclasts observed. It has 
been noted by other authors that OPG production from osteoclasts (rather than 
osteoblasts) is significantly elevated in the late phase of osteoclastogenesis, and 
so potentially the lower concentration identified is a result of the nanokick group 
not having many terminally differentiated osteoclasts. Furthermore, silencing of 
osteoclast-derived OPG is associated with lower levels of TRAP and cathepsin-K, 
and therefore, reduced bone resorption (Kang JH et al, 2014). This conforms to 
the osteoclast functional assessment result presented earlier in the chapter.  
Finally, metabolomics analysis was undertaken to gain further insight into the 
underlying mechanisms that potentially drive the changes observed. In both the 
M-CSF and RANKL group similar trends were observed. Specifically, there were 
reductions in the synthesis of key amino acids and inhibition of inflammatory 
pathways. This is potentially significant given both IL-6 and TNF-α were found to 
be reduced in preceding experiments. In a separate study examining the effects 
of vibration on macrophages, Pongkitwitoon et al found a similar pattern, with a 
significant reduction in IL-6, TNF-α and IFN-ϒ, and promotion of a M2 macrophage 
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phenotype following stimulation (Pongkitwitoon S et al, 2016). Regarding 
osteoclasts, Kulkarni et al found their differentiation to be reduced following 
mechanical stimulation secondary to inhibition of DC-STAMP – a downstream factor 
stimulated by RANKL (Kulkarni RN et al, 2013). Taken collectively, the RT-qPCR, 
ELISA and metabolomics results indicate a trend towards a lower inflammatory 
state in the nanokick group which would support the observations of reduced 
osteoclast numbers and function. Although this is promising, it is difficult to draw 
definitive conclusions from the metabolomics data and so further experiments 
would need to be conducted to validate the results seen. 
79 
 Nanoscale vibration of co-culture 
4.1 Introduction 
In the previous chapter, the effects of nanoscale vibration on a CD14+ culture 
were discussed. By studying this cell type in relative isolation, this allowed an 
assessment of how macrophages and osteoclasts respond to vibration without the 
influence of MSCs and osteoblasts. Ultimately, however, these cells do not exist 
in isolation. Rather, in the bone marrow niche, they are one component of a larger 
environment that functions through the complex interplay between differing cell 
types (Chen X et al, 2018).  
As discussed in Chapter 1.1, bone is a complex environment containing cells that 
both generate and remove bone, allowing for normal homeostasis. Bone 
remodelling relies on a continual process of formation (by osteoblasts) and 
resorption (by osteoclasts) and is dependent on the interaction between the two 
cell types. Osteoblasts are derived from undifferentiated MSCs in contrast to 
osteoclasts which originate from HSCs (Buckwalter JA et al, 1996). Osteoblasts 
express receptor activator RANKL, which binds to its receptor, RANK, on 
osteoclasts and their precursors, leading to their activation and increased bone 
resorption. In contrast, OPG is a soluble decoy receptor, also produced by 
osteoblasts that binds to RANKL, preventing its interaction with RANK and 
therefore limiting bone resorption (Roodman GD, 1999). Given the close 
interaction between osteoblasts and osteoclasts, it is likely that a more bone like 
environment can be generated within the Nanokick bioreactor through use of both 
MSCs and BMHCs. A recent development in the area of tissue culture has been the 
co-culture technique (Young PS et al, 2015). This method involves combining MSCs 
and BMHCs from the same human bone marrow. It allows for a more accurate 
representation of the in vivo environment, enabling us to study how well the two 
cell types interact and generate more bone-like graft materials. The technique 
for processing this culture is detailed in Chapter 2.2. In a further effort to produce 
an environment more akin to the bone marrow niche, some experiments will be 
performed in 3D as well as 2D given these cells will normally interact in three 
dimensions.  
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4.2 Materials and methods 
Experiments were conducted as detailed in the Materials and Methods chapter. As 
with the CD14+ culture, standard laboratory techniques and practices were 
followed. Cell numbers were kept standard across all experiments and 24 well 
plates used. Different time points were chosen from the CD14+ culture. As RANKL 
was not added, osteoclast formation was not present until around day 14. 
Furthermore, certain experiments that assess osteoblast function, such as Von 
Kossa staining, require a greater period of culture time for the desired effect to 
be observed (e.g. mineralisation). As such, the time points chosen were days 7, 
14, 21 and 28. 
4.3 Results 
4.3.1 Osteoclast differentiation  
As with the CD14+ culture, osteoclasts were defined as TRAP positive cells 
containing three or more nuclei. This allowed differentiation from other TRAP 
positive cells that would be present in the co-culture, namely macrophages.  
A significant reduction in osteoclast number was observed in the nanokick group 
after 28 days of stimulation (Figure 4:1, mean cells per well 1641 in control group 
cf 1077 in nanokick, p=0.0019). Although the number of osteoclasts observed 
varied between donors, the reduction in the nanokick group was present 
throughout. This 34.4% reduction is comparable to the reduction in osteoclasts 
numbers observed in the CD14+ culture. The time point was different for the 
CD14+ culture (day 7 cf day 28) due to the addition of RANKL in this condition as 
discussed in Chapter 4.2, but mature osteoclasts were present in both cell cultures 
at their respective end points.  
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Figure 4:1 Co-culture osteoclast count. 
Following 28 days of culture, TRAP staining demonstrated a significant reduction in osteoclasts 
numbers in the nanokick group. This reduction was of a comparable proportion to the CD14+ culture. 
Graph shows mean +/- SD. ** = p<0.01, by t-test. N=3 cell donors.  
Just as with the CD14+ culture, measurement of mean osteoclast area in the co-
culture demonstrated a reduction in the nanokick group (Figure 4:2, 5.5 mm2 cf 
4.1 mm2, p=0.03). Given that osteoclasts are formed through the fusion of smaller 
cells, there can be a wide range of potential areas observed, as illustrated in 
Figure 4:3. This helps explain the large standard deviation present.  
 
Figure 4:2 Co-culture osteoclast area. 
Similar to the CD14+ culture, a significant reduction in osteoclast area was observed in the nanokick 
group after 28 days of culture. Graph shows mean +/- SD. * = p<0.05, by t-test. N=3 cell donors. 
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Figure 4:3 TRAP stained co-culture image. 
10 x magnification brightfield microscopy image. The purple coloured multinucleated cells are 
osteoclasts. The osteoclasts are surrounded by smaller TRAP positive macrophages. In the co-
culture, osteoclasts were typically around the periphery of the well, whereas MSCs/osteoblasts were 
more prolific in the central regions. It is not clear why this pattern was present, but was found to be 
the case in all samples. Previous studies did not find any significant differences in nanoscale 
displacement across the surface of the well that would account for this (Tsimbouri PM et al, 2017a). 
It potentially occurred due to the co-culture method requiring HSCs to be seeded several days after 
the MSCs had adhered to the well. This could potentially lead to the HSCs spreading out towards 
the periphery of the well if MSCs were already adhering to the centre.  
4.3.2 AlamarBlue cell viability assessment 
Given the observed differences in osteoclast number between the two groups, cell 
viability was assessed through use of alamarBlue to determine whether increased 
cell death or reduced metabolic activity was a factor. This was performed at day 
7, 14 and 21. Although no difference was observed at day 7 or 21, a significant 
increase in alamarBlue reduction was found at day 14 (Figure 4:4, p=0.0056) in 
the nanokick group. This therefore indicates that increased cell death or reduced 
metabolic activity is not responsible for the reduction in osteoclast numbers 
observed in this group.  
100 µm 
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Figure 4:4 alamarBlue cell viability assay of co-culture. 
Cell metabolic activity and viability was assessed via the alamarBlue assay at day 7, 14 and 21. A 
significant increase in alamarBlue reduction was measured in the nanokick group at day 14. No 
difference was found at day 7 or 21. Graph shows mean +/- SD. ** = p<0.01, by t-test. N=3 cell 
donors. 
4.3.3 Cell viability in 3D collagen gel 
Prior to experiments being conducted in 3D collagen gels, an assessment of the 
ability of the co-culture cells to survive was required. Live-dead staining was 
performed to visualise and measure the proportion of living cells in the 3D culture. 
This demonstrated >99% living cells present in the culture after seven days 
incubation (Figure 4:5). This therefore confirmed the 3D technique was able to 
support this cell culture. 
 
Figure 4:5 Live/dead stain microscopy images of 3D co-culture. 
A – 2 x magnification with green/red light composite images of entire well in 24 well plate. B & C – 
10 x magnification with green/red light composite images of selected areas of 3D collagen gel. >99% 
of cells were living in the gel. Green cells = live, red cells = dead.  
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4.3.4 Immunostaining  
In Chapter 1.18, it was highlighted that previous studies involving nanoscale 
vibration of MSCs found features suggestive of increased cytoskeleton tension. 
Immunostaining was therefore performed in this study to determine whether this 
would still be the case when macrophages and osteoclasts were present in the 
culture.  
A significant increase in vimentin (p=0.01) and tubulin (p=0.03) staining intensity 
was found in the nanokick group (Figure 4:6 and 4:7). Given that both of these 
proteins are key components of the cytoskeleton, being responsible for tensile 
stiffness (Fletcher DA and Mullins RD, 2010), it can be postulated that greater 
cytoskeleton tension was present in the nanokick group.  
No difference was found in vinculin staining intensity (Figure 4:8). This is perhaps 
not surprising, however. Other authors found vinculin dispersion to be altered 
following nanoscale vibration, with movement from the periphery to the cells base 
and projections (Nikukar H et al, 2013). This suggests there may be no difference 
in the quantity of vinculin present, just its location within the cell. A similar 
appearance was present in this study, as demonstrated in Figure 4:9. The 
distribution is present throughout the cell in the nanokick group, rather than being 
focused towards the periphery. Furthermore, the nanokick cells took on a more 
elongated appearance, compared to the relatively round/square composition of 
the control. In being elongated, or “stretched’, it is possible this reflects the 
greater cellular tension that is present. Given the alterations in these surrogate 
markers of cytoskeleton tension, this infers the current study is in keeping with 
the finding of other authors. As such, the presence of macrophages and osteoclasts 
does not significantly affect the observable changes in cytoskeleton tension.  
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Figure 4:6 Vimentin staining intensity. 
Vimentin staining intensity was significantly increased in the nanokick group. Staining was performed 
after 28 days stimulation. Graph shows mean +/- SD. * = p<0.05, by t-test. N=3 cell donors. 
  
Figure 4:7 Tubulin staining intensity. 
Vimentin staining intensity was significantly increased in the nanokick group. Staining was performed 
after 28 days stimulation. Taken alongside the vimentin result above, this suggests increased 
cytoskeleton tension was present in the nanokick group. Increased cytoskeleton tension is 
associated with the promotion of osteogenesis in MSCs. Graph shows mean +/- SD. * = p<0.05, by 
t-test. N=3 cell donors. 
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Figure 4:8 Vinculin staining intensity. 
There was no difference in vinculin staining intensity between the two groups following 28 days of 
stimulation. There were changes in the distribution of vinculin, however, as seen in the figure below. 
Graph shows mean +/- SD. N=3 cell donors. 
 
Figure 4:9 Vinculin staining of co-culture. 
10 x magnification immunofluorescence images of co-culture demonstrating differences in 
distribution if vinculin between the control and nanokick group following 28 days culture. Vinculin can 
be seen located predominantly at the periphery of the control cells, compared to throughout the 
nanokick cells. The cell shapes also differed, with more elongation noted in the nanokick group. 
Vinculin = green, DAPI stained nucleus = blue. 
Staining for the presence of an actin ring was subsequently undertaken. An actin 
ring is an indicator of mature osteoclastogenesis. This was therefore undertaken 
to provide evidence the co-culture technique could support the development of 
this cell type. Both the control and nanokick groups stained positively for an actin 
ring (Figure 4:10), thus supporting the use of this culture technique.  
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Figure 4:10 Actin ring staining of osteoclasts in co-culture. 
Both images demonstrate the presence of an actin ring in the osteoclasts; a feature indicative of 
mature osteoclast formation. The white arrows point to the actin ring. N = an osteoclast nuclei, 
stained with DAPI. M = MSC present alongside the osteoclast as part of the co-culture.  
4.3.5 Scanning electron microscopy 
TRAP staining had demonstrated a reduction in osteoclast numbers and area, and 
immunostaining identified possible alterations in cytoskeleton tension. SEM was 
therefore undertaken to identify any potential morphological changes between 
the control and nanokick group when viewed in more detail. Cells were cultured 
for 14 days and prepared for SEM as per Chapter 2.9.  
The microscopic appearance of the control and nanokick groups was broadly 
similar. Osteoclasts were observed in close relation to MSCs, with the 
characteristic filopodia being identified on the periphery of the osteoclasts. 
Filopodia play an important role in cell migration (Mattila PK and Lappalainen P, 
2008). The length and number of filopodia between the two groups was grossly 
similar. However, in the control group the occasional significantly larger 
osteoclast was observed (as depicted in Figure 4:11, A). No osteoclasts of a similar 
size were found in the nanokick group (Figure 4:12). This observation conforms 
with the TRAP staining result, where a greater mean osteoclast size was found in 
the control group.  
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Figure 4:11 SEM images of co-culture control. 
A – 200 x magnification displaying a large osteoclast surrounded by smaller osteoclasts. The image 
potentially illustrates fusion occurring given the close proximity of the cells. B – 5000 x magnification 
image of osteoclast filopodia and an adjacent MSC. OC = osteoclast; M = MSC; arrow = filopodia.  
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Figure 4:12 SEM images of co-culture following nanoscale vibration. 
A – 600 x magnification image of osteoclast and MSC. B – 4000 x magnification image displaying 
filopodia in greater detail. OC = osteoclast; M = MSC; arrow = filopodia.  
4.3.6 Mineralisation analysis  
4.3.6.1 2D monoculture Von Kossa stain 
Von Kossa staining facilitates measurement of bone mineralisation. This 
measurement is therefore pertinent to this study as ultimately the aim of the 
Nanokick bioreactor is to stimulate osteogenesis and bone development. Other 
authors demonstrated greater levels of mineralisation for MSCs cultured in 
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isolation (i.e. no osteoclasts or other cell types were present) (Tsimbouri PM et 
al, 2017b, Childs PG et al, 2016). To confirm this effect, Stro-1+ cells (a more 
primitive subset of MSCs (Ning H et al, 2011)) were isolated and cultured for 28 
days. The entire well was imaged and the surface area with mineralisation present 
measured. A significant increase in mineralisation was found in the nanokick group 
(p=0.01, Figure 4:13). This corroborated the evidence presented by other authors 
and so Von Kossa analysis was then performed on the co-culture.  
 
Figure 4:13 Von Kossa staining of Stro-1+ MSC culture. 
The nanokick group had a significant increase in the percentage area of the well mineralised (0.14% 
cf 0.42%). Graph shows mean +/- SD. * = p<0.05, by t-test. N=3 cell donors. 
4.3.6.2 2D co-culture Von Kossa 
Nanoscale vibration produced a significant increase in mineralisation in the 2D co-
culture (Figure 4:14). The increased was of a similar proportion to the 
monoculture illustrated above (i.e. 3-fold change for Stro-1+ MSC culture, 2-fold 
change in co-culture). This suggests that the presence of macrophages and 
osteoclasts does not significantly interfere with the ability of osteoblasts to form 
bone when exposed to vibration.  
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Figure 4:14 Von Kossa stain analysis of 2D co-culture. 
A significant increase in mineralisation was found in the nanokick group (0.55% cf 1.06%). Graph 
shows mean +/- SD. *** = p<0.001, by t-test. N=3 cell donors. 
4.3.6.3 3D co-culture Von Kossa 
Collagen gels were seeded with the co-culture and stained with Von Kossa after 
28 days. A significant increase in mineralisation was found in the nanokick group 
(Figure 4:15), in keeping with the 2D data. Although the change was statistically 
significant, the absolute difference was comparatively small when viewed 
alongside the 2D results. It is possible that this is related to difficulties in assessing 
the quantity of mineralisation in collagen gels. In 2D, discrete nodules of 
mineralisation were present on the surface of the well that are measured and 
taken as a percentage of the surface area. In 3D, the collagen gels would reduce 
in size with time due to the contractile nature of MSCs. The degree of contraction 
was frequently greater in the nanokick group (Figure 4:16), which conforms to the 
increased cytoskeleton tension evidenced earlier in Chapter 4.3.4. Given the 
difference in size of the gels between groups, and the limitations of viewing 3D 
structures with microscopy, measuring the size of mineralised material as a 
percentage of the well surface area was not appropriate. Instead, mineralisation 
was measured and calculated as a percentage of the total size of the gel.  
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Figure 4:15 Von Kossa staining results of 3D co-culture. 
A significant increase in mineralisation was found in the nanokick group compared to the control. 
Graph shows mean +/- SD. * = p<0.05, by t-test. N=3 cell donors. 
A   B  
Figure 4:16 Images of 3D co-culture of control and nanokick groups. 
Figure A shows the control group, while B displays the nanokick group. Both images are of a single 
well in a 24 well plate after 14 days culture. As discussed in the 3D Von Kossa section, there was a 
visual difference in the size of the collagen gels between the two groups as the culture progressed. 
In Figure A there is minimal change in the appearance of the gel, with only slight contraction of the 
gel at the lower edge being visible. Conversely, in Figure B significant contraction of the gel can be 
seen, with the thick white oval shape representing the outer edge of the gel that initially occupied the 
entirety of the well.  
4.3.7 Gene expression  
RT-qPCR was performed to assess for differences in gene expression between the 
control and the nanokick group. This was performed in an effort to better 
understand the mechanism leading the aforementioned changes produced through 
nanoscale vibration. Cells were cultured as previously described, both in 2D and 
3D, and RNA extracted at days 7, 14, 21 and 28. The different approaches to RNA 
C
on
tr
ol
N
an
ok
ic
k
85
90
95
100
%
 A
re
a
 m
in
e
ra
lis
e
d
*
Chapter 4 Nanoscale vibration of co-culture 93 
extraction for the 2D and 3D culture are detailed in Chapter 2.12. A range of 
primers was chosen to provide adequate insight into osteoclastogenesis.  
4.3.7.1 2D co-culture RT-qPCR 
A significant reduction in IL-6 expression was observed in the nanokick group at 
day 14 (Figure 4:18, p=0.001). IL-6 is a pro-inflammatory cytokine that is crucial 
for the development of mature osteoclasts (Wu Q et al, 2017). OSCAR was also 
significantly reduced in the nanokick group (Figure 4:19, p=0.05). OSCAR plays an 
important role in osteoclast differentiation and maturation (Nemeth K et al, 
2011), and therefore reduced levels of this gene links to the lower number of 
osteoclasts observed through TRAP staining. Although not statistically significant, 
there appeared to be a trend towards higher production of OPG at days 7 and 14. 
OPG can limit bone resorption by inhibiting the action of RANKL, which drives 
osteoclast differentiation (Boyce BF and Xing L, 2007). Similar to the IL-6 and 
OSCAR findings, these results align themselves with the earlier findings of 
increased bone mineralisation and reduced osteoclast numbers. The heatmaps 
displayed below (Figure 4:17) highlight the trends in gene expression. Statistically 
significant changes are highlighted with independent graphs. 
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Figure 4:17 RT-qPCR heatmap of 2D co-culture. 
Day 7 - There were a number of differences in gene expression at this time point. OPG (an inhibitor 
of osteoclastogenesis) and ALP (an osteogenic gene) had the greatest upregulation in the nanokick 
group compared to the control. There was no statistically significant difference between either of the 
groups however. N=1 cell donor. Day 14 - There was a statistically significant reduction in IL-6 
production in the nanokick group at this time point. A number of other changes which did not reach 
statistical significance were also noted, including an increase in the osteoclast inhibitory gene OPG 
(also noted at day 7), and a reduction in pro-osteoclast gene RANKL. N=3 cell donors. Day 21 – 
there was a general trend towards a reduction in gene expression in the nanokick group. A 
statistically significant reduction in pro-osteoclast gene OSCAR was identified. N=3 cell donors. Day 
28 - The overall trend by day 28 was a reduction in gene expression in the nanokick group, although 
none of these differences reached statistical significance. The greatest difference was noted in the 
reduction of osteoclast markers TRAP and OSCAR in the nanokick group. N=1 cell donor. 
 
Figure 4:18 IL-6 RT-qPCR result of 2D co-culture at day 14. 
IL-6 proved to be the only statistically significant gene difference at day 14. The pro-inflammatory 
cytokine was reduced in the nanokick group. Graph shows mean +/- SD. ** = p<0.01, by t-test. N=3 
cell donors.  
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Figure 4:19 OSCAR RT-qPCR result of 2D co-culture at day 21. 
The pro-osteoclast gene OSCAR was significant reduced in the nanokick group. OSCAR is important 
in osteoclast differentiation and maturation (Nemeth K et al, 2011). Graph shows mean +/- SD. * = 
p<0.05, by t-test. N=3 cell donors. 
4.3.7.2 3D co-culture RT-qPCR 
There were two statistically significant changes in gene expression identified in 
the 3D co-culture: cathepsin-K (Figure 4:21) and OPN (Figure 4:22) were both 
increased in the nanokick group at day 7 (p<0.001 in both genes). Cathepsin-K is 
an enzyme responsible for the degradation of type 1 collagen, and therefore, bone 
resorption (Saftig P et al, 2000). The role of OPN is more complex. While some 
authors have shown OPN promotes bone formation during mechanical stress 
(Morinobu M et al, 2003a), others have found it inhibits mineralisation, prevents 
ectopic calcification and inhibits vascular calcification (Lund SA et al, 2009). 
Although not statistically significant beyond day 7, cathepsin-K and OPN remained 
elevated at days 14 and 21, whilst the majority of other genes were reduced in 
the nanokick group. This reversed by day 28, however, with the majority of genes 
being increased in the nanokick group, with the exception of pro-osteoclast 
markers OSCAR and cathepsin-K (Figure 4:20). As noted, these changes did not 
reach statistical significance. 
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Figure 4:20 RT-qPCR heatmaps of 3D co-culture. 
Day 7 - there were two statistically significant changes at this time point: an increased in both 
cathepsin-K and OPN in the nanokick group. Cathepsin-K is a pro-osteoclast gene, being involved 
in bone resorption, and conversely OPN is crucial to bone formation. N=2 cell donors. Day 14 - no 
statistically significant difference was found between any of the genes. N=4 cell donors. Day 21 - no 
statistically significant difference was observed between any genes at this time point, although there 
were similar trends to the day 14 results. N=4 cell donors. Day 28 – there was no statistically 
significant difference between any genes at this time point. There was a trend towards increases in 
gene expression in the nanokick group (with the exception of pro-osteoclast genes OSCAR and 
cathepsin-K), with the largest increase being observed in osteoblast marker ALP. N=2 cell donors.  
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Figure 4:21 Cathepsin-K RT-qPCR results of 3D co-culture at day 7. 
As highlighted in the heatmap above, cathepsin-K was significantly increased in the nanokick group. 
Graph shows mean +/- SD. *** = p<0.001, by t-test. N=2 cell donors. 
 
Figure 4:22 OPN RT-qPCR results of 3D co-culture at day 7. 
OPN was also significantly increased in the nanokick group at day 7. Graph shows mean +/- SD. *** 
= p<0.001, by t-test. N=2 cell donors.  
4.3.8 Protein assay  
RT-qPCR had demonstrated alterations at a gene level. An assessment of protein 
production by the cell cultures was next undertaken to determine whether they 
correlated with the gene changes. Three proteins were examined: IL-6, TNF-α 
(both osteoclast stimulatory) and OPG (osteoclast inhibitory). The ELISA 
experiments were performed as detailed in Chapter 2.13. Two times points were 
assessed: day 14 and 21. Both times points were conducted in 2D and 3D. 
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4.3.8.1 2D ELISA 
There were no significant differences in protein levels identified at day 14 (Figure 
4:23). However, IL-6 was noted to be slightly lower in the nanokick group (1606 cf 
1384 pg/ml). When comparing each of the three individual donors, one was 
significantly lower in the nanokick group (1435 cf 960 pg/ml, p=0.01). On review 
of the three OPG donors, one was found to have significantly higher levels in the 
nanokick group (4186 cf 5173, p=0.007). 
Moving on to day 21, a significant reduction in IL-6 was found in the nanokick group 
(Figure 4:24). The lower level of IL-6 ties in with the similarly significant reduction 
in this gene identified in the RT-qPCR analysis at day 14. As with the day 14 ELISA 
data, further analysis of each individual donor revealed one had a significant 
increase in OPG (7989 cf 9279 pg/ml, p=0.02).  
 
Figure 4:23 ELISA result of 2D co-culture at day 14. 
No significant difference was found in any of the protein levels at this time point. IL-6 levels were 
lower but this was no statistically significant.  Graph shows mean +/- SD. N=3 cell donors.  
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Figure 4:24 ELISA result of 2D co-culture at day 21. 
A significant reduction in IL-6 was observed in the nanokick group (2059 cf 1681 pg/ml). There was 
no difference in TNF- α and OPG production. Graph shows mean +/- SD. * = p<0.05, by t-test. N=3 
cell donors.  
4.3.8.2 3D ELISA 
At day 14, no significant differences were identified between the two groups 
(Figure 4:25). The same picture was present at day 21 (Figure 4:26). However, 
when each individual donor was examined, a significant reduction in IL-6 was 
found in all three in the nanokick group (Figure 4:27). The wide disparity between 
the donors resulted in a non-significant result when combined. It is not surprising 
that there will be differences found between individuals, but regardless of 
inherent disparities nanoscale vibration produced a reduction in the secretion of 
IL-6. This conforms to the 2D ELISA and RT-qPCR results.  
 
Figure 4:25 ELISA results of 3D co-culture at day 14. 
There was no significant difference between any of the assays at day 14. Graph shows mean +/- 
SD. N=3 cell donors. 
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Figure 4:26 ELISA results of 3D co-culture at day 21. 
Although there was no difference in any of the assays at day 14, all three of the IL-6 results when 
analysed independently showed a significant reduction in the nanokick group. This is highlighted in 
Figure 4:27. Graph shows mean +/- SD. N=3 cell donors. 
 
Figure 4:27 ELISA IL-6 result of 3D co-culture at day 21. 
When each donor was examined independently, all were found to have a significant reduction in the 
nanokick group. The variation between donors highlights the natural disparity that can be present 
when comparing individuals. Donor 1 – 3316 cf 2547 pg/ml. Donor 2 – 220 cf 169 pg/ml. Donor 3 – 
729 cf 555 pg/ml. Graph shows mean +/- SD. ** = p<0.01, *** = p<0.001, by t-test. 
4.3.9 Metabolomics 
4.3.9.1 2D co-culture 
Metabolites were extracted from the 2D and 3D cultures at day 14 and 21. 
Experiments were performed as detailed in Chapter 2.15. IPA was used to analyse 
the data and produce graphs of the highest scoring pathways and networks.  
At both day 14 and 21, the majority of significant changes observed in the pathway 
analysis were in relation to amino acid synthesis (Figure 4:28). On review of the 
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literature, some of these amino acids have been found to play significant roles in 
bone formation and osteoclastogenesis. Proline is a key constituent of collagen 
(Barbul A, 2008), one of the most abundant components in bone (Tzaphlidou M, 
2008), and was increased in the nanokick group. Conversely, both glutamine and 
serine were reduced. Glutamine is essential for osteoclast differentiation (Indo Y 
et al, 2013), and serine is required for NFAT2 induction by RANKL as discussed in 
the CD14+ metabolomics results section (Ogawa T et al, 2006, Pollari S et al, 
2011). The antioxidant glutathione was also reduced in the nanokick group. 
Although previously thought to inhibit osteoclastogenesis, it has since been shown 
to accelerates osteoclast differentiation by promoting TNF-α stimulated 
osteoclast formation (Fujita H et al, 2019).  
 
Chapter 4 Nanoscale vibration of co-culture 102 
 
 
Chapter 4 Nanoscale vibration of co-culture 103 
 
Figure 4:28 Metabolomics pathway analysis of 2D co-culture. 
Metabolite analysis with IPA identified a number of significant changes between the control and 
nanokick group. Figure A = day 14, figure B = day 21. There was a trend towards reductions in amino 
acid metabolism at both time points in the nanokick group, including glutamine, serine and arginine. 
Some potentially significant amino acids, such as proline which is a key constituent of collagen, were 
increased. Glutathione, an antioxidant that plays a role in promoting osteoclast differentiation, was 
reduced at day 14. The threshold for significance is p <0.05 with Fisher’s exact test. N=3 cell donors.  
The top scoring networks were then analysed. At day 14, a number of important 
complexes were predicted to be inhibited in the nanokick group (Figure 6:3). 
Several of these were also found to be inhibited in the CD14+ culture and, as 
discussed in Chapter 3.3.9, play a role in promoting osteoclastogenesis. These 
included NADPH oxidase, IL-1, JNK, PARP and NF-κB. Unlike the CD14+ culture, 
LDL – a stimulator of osteoclastogenesis (Luegmayr E et al, 2004) – was inhibited. 
Other factors found to be inhibited were hypoxia-inducible factor 1 (HIF1) and 
CCAAT/enhancer binding protein (C-EBP), both of which are required for 
osteoclast differentiation and activation (Chen W et al, 2018, Miyauchi Y et al, 
2013). There were also increases in osteoblast stimulatory markers. These 
included AMPK and ALP. AMPK both promotes the survival of osteoblasts and 
negatively impacts osteoclast differentiation by suppressing RANKL (Lee YS et al, 
2010). Table 4:1 highlights the key complexes that were altered. The full network 
analysis is presented in the Appendices.  
Moving on to the day 21 network, there were similarities observed. In particular, 
there was a predicted reduction in many of the inflammatory and osteoclast 
stimulatory pathways, including IL-1, JNK, LDL, C/EBP and NF-κB. Additional new 
complexes with similar function were also identified (Figure 6:4). TNF was found 
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to be inhibited; a feature noted in the CD14+ metabolomics results. In contract to 
the CD14+ results, however, AhR was found to be inhibited – a transcription factor 
that is activated by RANKL to promote osteoclast formation (Izawa T et al, 2016). 
Ras-proximate-1 (Rap1) was also inhibited. A previous study found when this 
protein was reduced, osteoclast mediated resorption was impaired due to 
cytoskeleton changes that prevent adhesion to bone (Zou W et al, 2013). The 
pathway for integrin subunit alpha M (ITGAM) was found to be inhibited. This 
integrin that is upregulated by TNF is expressed by pre-osteoclasts derived from 
the bone marrow niche, and ITGAM silencing leads to impaired osteoclast 
differentiation and function (Yang G et al, 2017, Hayashi H et al, 2008). Table 4:2 
highlights the key complexes that were altered. The full network analysis is 
presented in the Appendices.  
Table 4:1 Selected complexes activated and inhibited in metabolomics network analysis of 
nanokick 2D day 14 co-culture group 
Inhibition  Activation  
HIF1 ALP 
NF-κB AMPK 
NADPH oxidase 
IL-1 
C/EBP 
PARP 
JNK 
LDL 
ERK 
 
Table 4:2 Selected complexes activated and inhibited in metabolomics network analysis of 
nanokick 2D day 21 co-culture group 
Inhibition  Activation  
TNF ALP 
NF-κB 
IL-1 
C/EBP 
PLA2 
JNK 
LDL 
AhR 
Rap1 
ITGAM 
IL-13 
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4.3.9.2 3D co-culture 
Metabolites were extracted from 3D gels at day 14 and 21 using the same methods 
detailed in Chapter 2.15. IPA was again used to analyse the data and produce 
charts of the top scoring networks and pathways.  
On analysis of the top scoring pathways, the overall trend observed was a 
reduction in amino acid synthesis, similar to that of the 2D culture. There were 
specific changes that aligned with the 2D culture, for example reductions in 
glutamine, serine and glutathione. All of these compounds have been found to 
stimulate osteoclastogenesis (Indo Y et al, 2013, Takarada T et al, 2012, Fujita H 
et al, 2019). There were some notable differences observed, however. In contrast 
to the 2D culture, proline was found to be reduced in the nanokick group. As 
previously noted, this amino acid is a key component of collagen and, therefore, 
bone. The significance of this result given the cells were cultured in collagen is 
difficult to determine. tRNA charging was also increased in the nanokick group at 
day 21 (Figure 4:31). tRNAs play a role in amino acid transport and protein 
synthesis (Lodish H et al, 2000), and so this is interesting given the observed trend 
towards lower amino acid levels. However, given that there are both MSCs and 
BMHCs in this culture, and nanoscale vibration has been shown to have differing 
effects on these cell lines, it is perhaps not surprising that there are conflicting 
patterns present. 
On analysis of the top scoring networks there were several similarities with the 
preceding experiments. At day 14, the nanokick group was found to have inhibition 
of multiple inflammatory and osteoclast stimulatory factors, including TNF, JNK, 
IL-1, NADPH oxidase, pro-inflammatory cytokine, AhR, HIF1, ITGAM and 
interferon- ϒ (IFN-ϒ) (Figure 6:5). IFN-ϒ stimulates osteoclast formation and bone 
resorption by promoting increases in RANKL and TNF-α (Gao Y et al, 2007). The 
osteogenic marker ALP was increased. A similar pattern was present at day 21, 
with the additional inhibition of osteoclast stimulatory factors epidermal growth 
factor receptor (EGFR) and C-X-C chemokine receptor type 2 (CXCR2). EGFR 
promotes osteoclast differentiation by upregulating RANKL signalling pathways. 
CXCR2 is a chemokine that promotes inflammation and stimulates osteoclast 
differentiation and function (Hardaway AL et al, 2015). However, in contrast to 
previous cultures there was an increase in some pro-osteoclast markers, namely 
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HIF1, LDL and NADPH oxidase (Figure 6:6). This therefore presents a more 
ambiguous picture compared to the prior conditions that predicted a widespread 
inhibition of inflammatory complexes. Tables 4:3 and 4:4 highlights the key 
complexes that were altered. The full network analyses are presented in the 
Appendices. 
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Figure 4:29 Metabolomics pathway analysis of 3D co-culture. 
Metabolite analysis with IPA identified a number of significant changes between the control and 
nanokick group. Figure A = day 14, figure B = day 21. There was a trend towards reductions in amino 
acids at both time points.  Conversely, tRNA – which plays a role in amino acid transport and protein 
synthesis – was found to be increased. The osteoclast-stimulatory antioxidant glutathione was 
reduced. The threshold for significance is p <0.05 with Fisher’s exact test. N=3 cell donors.  
Table 4:3 Selected complexes activated and inhibited in metabolomics network analysis of 
nanokick 3D day 14 co-culture group 
Inhibition  Activation  
TNF ALP 
IL-1 SIRT6 
PLA2 AMPK 
JNK 
AhR 
ITGAM 
HIF1 
NADPH oxidase 
Pro-inflammatory 
cytokine 
IFN-ϒ 
 
Table 4:4 Selected complexes activated and inhibited in metabolomics network analysis of 
nanokick 3D day 21 co-culture group 
Inhibition  Activation  
TNF HIF1 
IL-1 LDL 
JNK NADPH oxidase 
AhR 
IFN-ϒ 
EGFR 
CXCR2 
C/EBP 
 
4.4 Discussion  
In the CD14+ results chapter, the effect of nanoscale vibration on an isolated 
culture of macrophages and osteoclasts was discussed. Whilst it was beneficial to 
examine this area, these cell types ultimately do not exist in isolation. Rather, 
they form but one component of the bone marrow niche. As detailed in the 
introduction chapter, osteoclasts have a co-dependent relationship with 
osteoblasts, both in terms of their function and survival. Specifically, factors 
produced by osteoblasts can stimulate or inhibit osteoclast function (Marino S et 
al, 2014). One of the primary objectives of the Nanokick bioreactor – and other 
tissue engineering technologies – is to stimulate bone development and eventually 
be used in a clinical context. Therefore, examining what effect nanoscale 
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vibration has on a co-culture of osteoblasts and osteoclasts that is representative 
of the in vivo environment provided valuable new insights.  
Firstly, osteoclast numbers were determined following stimulation. Similar to the 
CD14+ culture, a significant reduction in osteoclasts was observed in the nanokick 
group. Interestingly, this reduction was of a similar proportion to the CD14+ 
culture, i.e. approximately 30%. This suggests the effect of vibration is not 
enhanced or inhibited by the presence of MSCs and osteoblasts. Osteoclast size 
was also reduced in the nanokick group. This was noted objectively with 
measurement of TRAP stained cells, but also subjectively with SEM where the 
occasional significantly larger osteoclast was noted in the control but not the 
nanokick group. There were no other morphological differences noted between 
groups on SEM, however, and immunofluorescence confirmed the presence of an 
actin ring in both cultures – a feature consistent with mature osteoclast formation. 
Although a reduction in osteoclasts may be beneficial when attempting to 
stimulate bone growth, it is important that functioning osteoclasts are present. 
Otherwise the normal remodelling process will not occur, leading to abnormal 
bone production. Just as with the CD14+ culture, alamarBlue assay revealed an 
increase in cell metabolic activity and viability in the nanokick group, suggesting 
cell death is not the cause of the reduced osteoclast numbers. 
An assessment of the MSCs and osteoblasts in the co-culture was then undertaken. 
Prior studies demonstrated increases in osteogenesis when MSCs were exposed to 
nanoscale vibration (Tsimbouri PM et al, 2017b, Nikukar H et al, 2013, Pemberton 
GD et al, 2015). It was uncertain whether osteoclasts would ultimately negate this 
effect. Firstly, immunostaining was performed. This identified increases in 
vimentin and tubulin staining intensity; a feature suggestive of increased 
cytoskeleton tension. Tubulin is a key component of microtubules, one of the most 
rigid components of the cytoskeleton (Fletcher DA and Mullins RD, 2010). 
Microtubules help control cell shape and mechanics, particularly long extensions, 
and bear loads to stabilise the cytoskeleton (Brangwynne CP et al, 2006). Vinculin 
is a crucial protein in focal adhesions (FA) (Chang CW and Kumar S, 2013). FA are 
mechanosensitive structure which engage with the ECM and interact with stress 
fibres to generate tension (Rikitake Y and Takai Y, 2011). MSCs have been shown 
to have greater cytoskeleton tension when differentiating down an osteogenic 
route compare to adipogenic or chondrogenic (Mathieu PS and Loboa EG, 2012). 
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This result therefore suggests nanoscale vibration promotes osteogenesis via 
cytoskeleton changes. Related to increased cytoskeleton tension, contraction of 
the collagen gels was notably more significant in the nanokick group, suggesting 
greater contractility of the MSCs in this culture. Von Kossa staining was then 
performed to analyse mineralisation. In both the 2D and 3D cultures, a significant 
increase in mineralisation was identified in the nanokick group. This confirmed 
that osteogenesis can be stimulated through nanoscale vibration when osteoclasts 
are present.  
As with the CD14+ culture, RT-qPCR was undertaken in an attempt to better 
understand the underlying mechanism responsible for the observed changes 
detailed above. In the 2D culture, significant reductions in IL-6 and OSCAR were 
found. IL-6 promotes osteoclast differentiation by enhancing expression of RANKL 
(Wu Q et al, 2017). OSCAR also stimulates osteoclast differentiation, and has been 
implicated in diseases such as rheumatoid arthritis and osteoporosis (Nemeth K et 
al, 2011). Reductions in these genes therefore conforms to the lower number of 
osteoclasts observed. In the 3D culture, however, cathepsin-K and OPN were found 
to be significantly elevated in the nanokick group at day 7. Cathepsin-K is a 
protease that promotes bone degradation, and is stimulated by cytokines such as 
RANKL (Troen BR, 2006). Interestingly, there was no increase in RANKL noted at 
this time point. The significance of the raise OPN level is less clear. OPN has been 
shown to play a role in the formation of osteoclast podosomes (Duong LT et al, 
2000), as well as their survival (Singh A et al, 2018) and motility (Chellaiah MA and 
Hruska KA, 2003). Equally, however, OPN is produced by osteoblasts and 
osteocytes in response to mechanical stimulation as a positive factor for bone 
formation (Morinobu M et al, 2003b). OPN was also found to be elevated during 
distraction osteogenesis, with the hypothesis that early expression (similar to the 
raised level at day 7 noted in this study) may facilitate pre-osteoblast proliferation 
and migration (Perrien DS et al, 2002). In a separate study involving nanoscale 
vibration of MSCs, OPN was also found to be increased at day 7. It is interesting to 
note this consistent finding even when HSCs are present in the culture (Tsimbouri 
PM et al, 2017a).  
Following the RT-qPCR results, ELISA was undertaken. In the 2D culture, a 
significant reduction in IL-6 was found. In 3D, although IL-6 was not significantly 
reduced when the data were pooled, each of the three donors had a significant 
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reduction in the nanokick group. The cumulative result did not reach statistical 
significance due to variation in IL-6 levels between donors. This does demonstrate, 
however, that irrespective of donor differences, IL-6 was reduced by nanoscale 
vibration. This result also aligns with the significant reduction in IL-6 found with 
RT-qPCR, albeit at a different time point. 
Metabolite analysis was then performed to gain further insight into the biological 
process driving the reduction in osteoclast numbers. Reassuringly, a similar 
picture appeared to that of the CD14+ culture, suggesting there may be a shared 
underlying mechanism. The common theme that emerged was of an inhibition in 
inflammatory pathways, many of which promote osteoclastogenesis. For example, 
TNF, IL-1 and JNK appeared to be consistently inhibited across all conditions, to 
name a selected few. Overlaying the IL-6 pathway (presented in the Appendices) 
also demonstrated inhibition of a number of complexes which is of interest given 
the RT-qPCR and ELISA result. There are few studies performing metabolomic 
analysis of mechanically stimulated MSCs/HSCs, however other authors have used 
RT-PCR to find ALP is increased with nanoscale vibration of MSCs (Tsimbouri PM et 
al, 2017a) which mirrors the metabolomics result of this study. As with the CD14+ 
result, the metabolomics results are potentially promising but confirmation is 
required by conducting further experiments to validate the observations.  
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 General discussion 
5.1 Introduction 
The ability to influence stem cell fate represent one of the primary goals of cell 
engineering. This is frequently with the aim of developing methods to produce 
replacement human tissue for either medical research or novel treatments (Mali 
P and Cheng L, 2012). With the ageing population, in whom degenerative and 
pathological conditions are more prolific, the demand for tissue and organs has 
never been higher (Wang W and Yeung KWK, 2017, White SL et al, 2014, Olson JL 
et al, 2011). Bone represents the second most commonly transplanted tissue and 
as such has been subject to extensive research (Amini AR et al, 2013). 
Additionally, there are well-evidenced disadvantages to the current graft options 
which has prompted investigation into new technologies. The current “gold 
standard” approach involves harvesting bone graft from the same patient (i.e. 
autologous), at sites such as the iliac crest (Dimitriou R et al, 2011). This has the 
advantage of being osteoinductive (growth factors and osteoprogenitor cells) and 
osteoconductive (bone scaffold) (Bauer TW and Muschler GF, 2000). However, in 
addition to significant pain this procedure is associated with a number of potential 
complications, including damage to blood vessels and nerves, pelvic fracture and 
herniation of abdominal contents (Ahlmann E et al, 2002, Dimitriou R et al, 2011).  
Current alternatives to autograft are also not without their own drawbacks. 
Allograft – i.e. tissue from another individual – requires irradiation or freeze-
drying, leading to the loss of osteoinductive factors (Delloye C et al, 2007). And 
growth factors used to stimulate new bone development, such as BMP-2, have 
been associated with cancer (Carragee EJ et al, 2013, Raida M et al, 2005). Tissue 
engineering aims to overcome these shortfalls by producing lab grown bone that 
does not require additional surgical procedures or potentially harmful growth 
factors, yet stimulates healing and can meet the increase in demand (Olson JL et 
al, 2011).  
Crucial to this goal is developing an understanding of the mechanisms that drive 
bone growth, and how they can be utilised to guide stem cell fate. One such 
mechanism is mechanical stimulation. The concept of force having an impact on 
bone formation is not new. It is well established that athletes involved in physical 
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activity increase their bone mass, whilst immobility and low gravity environments 
reduce bone quality (Amin S, 2010). Utilising mechanical stimulation in tissue 
engineering is therefore a logical progression. This has the benefit of avoid growth 
factors and their potential problems.  
Varying techniques have been described within the literature to exert mechanical 
force on cells. These include, but are not limited to, compressive stress (Wang YK 
and Chen CS, 2013), tensile stress (Tang N et al, 2012) and vibration (Tsimbouri 
PM et al, 2017b). One technique that previously received significant attention with 
regard to bone healing was low intensity pulsed ultrasound (LIPUS). In 2008, 21% 
of Canadian trauma surgeons prescribed LIPUS for tibial fracture (Busse JW et al, 
2008). This non-invasive technique utilises acoustic energy to exert mechanical 
stress at the fracture site (Mundi R et al, 2009). A frequency of 1.5 MHz is typically 
utilised (Claes L and Willie B, 2007). It is believed that this produces movement 
at the fracture ends, with a range of 0.15 nm (Pounder NM and Harrison AJ, 2008) 
to 2 mm (Claes L and Willie B, 2007) bone end displacement being reported. This 
movement was thought to result in increases in osteogenic gene expression (Sena 
K et al, 2005), alterations in the cell cytoskeleton via integrins (Yang RS et al, 
2005) and recruitment of osteoprogenitor cells (Mundi R et al, 2009). Despite this, 
a range of outcomes were reported in the literature. The size of the surrounding 
soft tissue mass was reported as a potential reason for failure of treatment. 
Greater success was reported in superficial bones, such as the tibia and ulna, 
compared to deeper structures, such as the femur (Mayr E et al, 2000). However, 
when multiple studies were pooled in a systematic review, no difference was 
found in return to work or number of subsequent operations. There was a possible 
reduction in days to full weight bearing, pain and radiographic union. However, 
when trials at high risk of bias were excluded, these benefits were no longer 
present (Schandelmaier S et al, 2017). As such, the use of LIPUS is no longer 
advocated (Poolman RW et al, 2017). It is tempting to draw similarities between 
LIPUS and nanoscale vibration given the fundamental principle of mechanical 
stimulation. However, given the different frequency, amplitude and external 
application of the stimulus such conclusions are not appropriate. 
In this thesis, nanoscale vibration has been investigated as a method of influencing 
stem cell differentiation and osteoclastogenesis. This bioreactor utilised the 
reverse piezo effect, whereby electrical energy is used to generate mechanical 
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force. Interestingly, the piezo effect can be observed in bone. When an electrical 
current is applied to bone, it causes mechanical deformation. Equally, mechanical 
stress produces polarisation (Reinish GB and Nowick AS, 1975).  
Electrical polarisation of bone has been suggested as one means by which bone 
remodelling occurs, with bone resorption taking place in positively charged areas 
and formation at negatively charged regions (Cerrolaza M et al, 2017b). Negative 
charge can be found in areas of compression (Fernández JR et al, 2012) and as 
such this conforms to Wolff’s law which states that mechanical loading leads to 
remodelling that will better equip the bone to deal with similar loads (Frost HM, 
2004). Vibration in the micrometre and millimetre range as a means of stimulating 
osteogenesis has previously been investigated by other authors and has been 
shown to promote osteogenesis (Zhou Y et al, 2011, Zhang C et al, 2012, Prè D et 
al, 2011). Given that many cell interactions occur on the nanoscale (Nikukar H et 
al, 2016), it was a logical progression to develop a bioreactor that delivers 
nanoscale vibration. Although a relatively recent innovation, the Nanokick 
bioreactor has shown promising results, with upregulation of osteogenesis in MSCs 
(Nikukar H et al, 2016, Nikukar H et al, 2013, Pemberton GD et al, 2015, Tsimbouri 
PM et al, 2017b).  
In the bone marrow niche, however, MSCs and osteoblasts do not exist in isolation. 
They live in a co-dependent relationship with a range of other cells, with one of 
the most significant of these being osteoclasts. The interplay between osteoblasts 
and osteoclasts is crucial to normal bone development, homeostasis and 
remodelling after injury. Any imbalance in this dynamic, particularly with regard 
to osteoclast function, can lead to pathological conditions, such as osteoporosis 
(Tang P et al, 2014, Mizuno A et al, 1998) and osteopetrosis (Saftig P et al, 1998, 
Naito A et al, 1999). The effect of nanoscale vibration on osteoclasts was hitherto 
not known. When considering this new technology as a means of producing lab 
grown bone graft, or even potentially using implantable vibration devices to 
stimulate osteogenesis, this information is crucial. The aim of this MD thesis was 
therefore to examine what response is elicited from osteoclasts following 
stimulation with the Nanokick bioreactor.  
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5.2 Osteoclastogenesis and osteoblastogenesis following 
nanoscale vibration 
In this study, a reduction in osteoclast number and size was observed following 
exposure to nanoscale vibration. Although these are the first reported outcomes 
in this area, some research has been performed utilising microscale vibration. 20 
µm displacements at 4 Hz reduced osteoclast differentiation and fusion in mouse 
cells, potentially through the suppression of dendritic cell-specific 
transmembrane protein (DC-STAMP), a regulator of osteoclast differentiation 
(Kulkarni RN et al, 2013) that is stimulated by RANKL (Kukita T et al, 2004). With 
vibration at 45 Hz and 50 µm Xie et al found mice tibia had a 30% reduction in 
osteoclast numbers – a similar proportion to what was found in this study. The 
authors also noted a 25% reduction in osteoclast-mediated resorption (Xie L et al, 
2006).  
Frequency also plays an important role. In a study which examined the correlation 
between frequency and expression of COX-2 – a prostaglandin essential for bone 
healing (Simon AM et al, 2002) – increases in frequency (5 – 100 Hz) were found to 
produce a linear increase in COX-2. A similar effect was found with nitric oxide 
(NO), which supports bone growth (Diwan AD et al, 2000) partly by detaching 
osteoclasts and inhibiting resorption (Mancini L et al, 1998). Conversely, 
increasing frequency resulted in lower levels of prostaglandin E2 (PGE2). PGE2 
stimulates osteoclast differentiation and resorption (Kaji H et al, 1996) and so 
taken alongside the increases in COX-2 and NO further confirms the importance of 
higher frequency vibration in osteogenesis (Bacabac RG et al, 2006). The Nanokick 
bioreactor delivers a frequency of 1000 Hz. This was based on prior studies which 
identified this as the most conductive to osteogenesis with MSC cultures 
(Pemberton GD et al, 2015, Nikukar H et al, 2016). The results of this thesis 
support the continued use of this frequency given the combination of increases in 
osteogenesis and reduction in osteoclastogenesis observed.  
Osteocytes, one of the most abundant cells in bone, have also been shown to be 
mechanosensitive. This is important given their role in cell signalling and 
orchestration of osteogenesis. In a separate study, vibration of mouse osteocytes 
at 10 µm was found to negatively influence osteoclastogenesis (Lau E et al, 2010). 
This was through a reduction in RANKL and PGE2 and increases in COX-2. Not only 
Chapter 5 General discussion  116 
were cell numbers reduced, but the size of the osteoclasts also. The number of 
nuclei is linked to an osteoclasts resorptive ability (Lees RL et al, 2001), with 
larger cells resorbing greater amounts of bone. Given the smaller size of 
osteoclasts observed in the nanokick group of this study, it can be surmised that 
their activity would be similarly reduced. Indeed, this was borne out in the 
functional assessment of Chapter 3.3.5, as the nanokick group had a significant 
reduction in resorption. 
The initial experiment performed in this study was TRAP staining, with the aim of 
identifying any differences in osteoclast differentiation following nanoscale 
vibration. Once the inhibitory effect was established, the underlying mechanism 
was initially investigated through RT-qPCR and ELISA. Some evidence was found 
to support the changes observed in TRAP staining and resorption analysis. At 
certain time points, M-CSF, TNF-α and IL-6 were found to be reduced; factors 
which would inhibit osteoclastogenesis. For example, IL-6 is involved in a number 
of pathological resorptive conditions, including rheumatoid arthritis, osteoporosis 
(Edwards CJ and Williams E, 2010) and primary hyperparathyroidism (Grey A et al, 
1996). However, cathepsin-K, OSCAR and OPG were both increased and decreased 
at different time points, which made a definitive interpretation of the results 
challenging. It is possible the inhibitory factors were of greater significance to 
osteoclast stimulation and differentiation. Equally, it may be that an examination 
of different genes and cytokines would have yielded more conclusive information. 
A broad range of markers was investigated in this study to cast a wide net, but it 
is certainly possible that a significant factor was missed. Given the complexity of 
the cellular process and multiple steps involved this is perhaps not surprising. 
Following the RT-qPCR and ELISA results, a metabolomic analysis was performed. 
This technique has been performed in MSC tissue engineering studies previously 
(Tsimbouri PM et al, 2017b). It has the benefit of obtaining a large volume of data, 
providing valuable insight into a range of biological processes. Equally, data 
overload can be an issue with this technique (Daviss B, 2005), leading to 
difficulties determining what results are both relevant and significant. In analysing 
the data from this study, only the top scoring networks and pathways deemed 
relevant to the cell culture were examined.  
The common theme that emerged across all experimental conditions was an 
inhibition of inflammatory pathways. Multiple complexes and cytokines were 
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consistently downregulated, such as TNF, JNK and NF-κB. Given the significance 
of these factors in the stimulation of osteoclastogenesis – and their correlation 
with the lower levels of TNF-α and IL-6 seen in the RT-qPCR and ELISA results – 
they represent a promising process through which nanoscale vibration may exert 
an effect on osteoclast differentiation and function. To conclude that inhibition 
of inflammatory factors is the underlying biological process that downregulates 
osteoclastogenesis based on these observations would be premature, however. 
Further metabolomic experiments are required to validate these results. 
While a reduction in osteoclast numbers, size and resorptive ability was 
demonstrated, it was also important to assess whether osteogenesis was 
influenced by the presence of cells from the HSC lineage. Following nanoscale 
vibration, alternations in MSC shape and cytoskeleton features were found. 
Specifically, cells were elongated with increases in vimentin and tubulin which 
suggests increases in cytoskeleton tension. Cellular tension is important in the 
determination of stem cell fate. Other authors have demonstrated that greater 
tension is associated with cells of an osteoblast lineage, compared to adipogenic 
cell lines which have lower tension (Robertson SN et al, 2018, Dalby MJ et al, 2007, 
Kilian KA et al, 2010b). It has been suggested that the cytoskeleton plays an 
important role in the transfer of mechanical force to the nucleus. When a force is 
transmitted through the ECM, it is detected by surface-adhesion receptors, such 
as integrins. Integrins are attached to the cytoskeleton, which are in turn 
integrated with the nuclear scaffold, nuclei and DNA of the cell. It is therefore 
possible that forces transmitted from outside the cell result in gene level changes 
via the cytoskeleton (Wang N et al, 2009). Figure 5.1 demonstrates a tensegrity 
model, illustrating that the cell cytoskeleton and nucleus alter in response to 
external stresses. 
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Figure 5:1 Mechanical force propagation. 
A – a computer stimulation of a cell tensegrity model, illustrating the connections between the 
cytoskeleton and nucleus that rearrange in response to sheer stress. B – a graphic representation of 
force (red dot) being detected by integrins on the cell surface and then transmitted through the 
cytoskeleton to the nucleus. It takes approximately 5 µs for forces to propagate from integrins to the 
nucleus. Images presented with permission from Springer Nature (Wang N et al, 2009).  
Bone mineralisation was also altered, with significant increases in the nanokick 
group in both 2D and 3D. The same technique was also performed on an isolated 
culture of MSCs. Although the increase in mineralisation was greater than the co-
culture (3-fold cf 2-fold increase) it suggests the presence of osteoclasts does not 
significantly impair bone formation. This is potentially a highly significant result. 
Whilst the current literature on nanoscale vibration confirmed increases in 
mineralisation in MSCs, it did not provide insight into what response vibration 
would elicit in vivo. The use of a co-culture method therefore provides useful 
information for any future studies involving whole marrow samples or implantable 
devices. 
5.3 Limitations  
There are several limitations to this work. Firstly, the number of donors per 
experiment could have been higher. This would have helped with the statistical 
analysis and as such provide more robust conclusions. In this study, the aim was 
to provide three donors per experiment as this would be in line with other 
research papers in the field (Tsimbouri PM et al, 2017a). However, this was not 
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achieved in all cases as a result of restrictions on donor sample availability, 
bioreactor space and, ultimately, time.  
Despite examining a number of genes, the RT-qPCR experiments did not yield a 
definitive answer. Specifically, there was not a common gene the was 
consistently up- or downregulated in response to nanoscale vibration that would 
explain the observed changes in osteoclast differentiation. It is possible 
selecting a different set of genes to analyse would have provided more 
certainty. Equally, the complexity of the cellular processes may mean that there 
is not one individual gene that we can attribute responsibility to. Taken 
alongside the ELISA and metabolomics data, however, the RT-qPCR results do 
appear to support the observed trend towards a state of lower inflammation. 
There are potentially factors that may have influenced the results which we 
could not examine for within the scope of this study. For example, electric fields 
have been shown to influence cell differentiation and growth (Taghian T et al, 
2015). It is possible that the Nanokick bioreactor produces an electric field that 
alters cell biology. In an effort to mitigate this and similar issues, all cell 
cultures – both control and nanoscale vibration groups – were placed in the same 
incubator in close proximity. Therefore, all cell conditions are more likely to be 
located a similar distance from any electric field produced. Linked with this, a 
magnetic field will be in close proximity to the nanokick group given the 
coupling of culture ware to the bioreactor. However, there is no evidence that 
even strong magnetic fields influence cell growth, survival or differentiation 
(Miyakoshi J, 2005). 
5.4 Future work 
This thesis highlighted the observed effect of nanoscale vibration on osteoclasts 
and a co-culture. Whilst morphological changes were undoubtedly present, the 
underlying mechanism is still not fully understood. Specifically, what gene changes 
drive the inhibition of osteoclastogenesis. RT-qPCR, ELISA and metabolomics 
suggested inhibition of a number of inflammatory and osteoclast stimulatory 
factors. Exploring additional genes through RT-qPCR could further our 
understanding of osteoclast biology. Additionally, inhibiting integrins and 
determining what effect this has on inflammatory pathways could provide valuable 
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insights. Conversely, supplementing the culture with inflammatory cytokines and 
assessing the response of both osteoblasts and osteoclasts would further develop 
our understanding of the role of inflammation in osteogenesis.  
As noted, microscale displacements and alternate frequencies were found to 
inhibit osteoclastogenesis in other studies. It may therefore be beneficial to 
explore different parameters with the Nanokick bioreactor and determine 
whether any significant difference is observed in osteoclast and MSC cultures. 
Equally, exploring whether the cells have a “memory” by providing intermittent 
or short-term stimulation would be beneficial as it would confirm whether the 
observed effects last when vibration is removed. This is of particular importance 
when considering transplantation of tissue-engineered graft. 
Finally, methods to optimise the delivery of primed cells to patients should be 
explored. This could include osteogenic scaffolds into which cells can be seeded. 
Such methods should be sterile, customisable and easy to work with in order to 
facilitate the safe and effective intra-operative delivery of osteogenic 
components. Furthermore, equipment that allows the volume of cells being 
stimulated to be upscaled, either through cultureware or bioreactor size, could 
be developed to meet the demands of clinical application. 
5.5 Conclusions  
In this thesis, the effects of nanoscale vibration on osteoclasts and a co-culture of 
osteoblasts and osteoclasts were discussed. A novel technology – the Nanokick 
bioreactor – was utilised to deliver the vibration. Without the addition of growth 
factors or complex techniques, the Nanokick bioreactor was found to inhibit 
osteoclastogenesis and stimulate osteogenesis. Despite these early promising 
results, further work is still required. A greater understanding of the underlying 
mechanisms driving the inhibition of osteoclastogenesis would be beneficial not 
just for this study, but also in considering potential therapeutic targets for 
conditions such as osteoporosis. It is hoped that with continued research and 
development, the Nanokick bioreactor will be utilised in the future to produce 
tissue-engineered bone graft for both clinical use and pharmacological research. 
Looking further still, wearable or implantable devices that can deliver localised 
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stimulation may be considered to enhance the treatment of musculoskeletal 
disease. 
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 Appendices  
6.1 Metabolomics network analysis 
 
 
Figure 6:1 Metabolomics network and selected pathways in the M-CSF group 
IPA network analysis illustrating the top scoring networks identified. There was a predicted trend 
towards inhibition of pro-inflammatory cytokines in the nanokick group. Potentially significant 
complexes that were inhibited include IL-1, TNF, NF-κB, JNK and pro-inflammatory cytokine. These 
complexes are indicated by the canonical pathway arrows for IL-6 and role of osteoblasts, 
osteoclasts and chondrocytes in rheumatoid arthritis. Blue = inhibition, orange = upregulation. CP = 
canonical pathway. N=3 cell donors. 
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Figure 6:2 Metabolomics network and selected pathways for +RANKL group. 
IPA network analysis illustrating some of the common networks identified. The overall predicted trend 
was an anti-inflammatory and osteoclast inhibitory change. Specifically, this occurred through 
alterations in TNF, NF-κB, pro-inflammatory cytokine, PARP, NADHP oxidase, PLA2, AMPK and 
SIRT6. However, there were also increases in LDL and AhR which conflicted with this trend. These 
potentially significant complexes are indicated by the canonical pathway arrows for IL-6 and role of 
osteoblasts, osteoclasts and chondrocytes in rheumatoid arthritis. Blue = inhibition, orange = 
upregulation. CP = canonical pathway. N=3 cell donors. 
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Figure 6:3 Metabolomics network and selected pathways for 2D day 14 co-culture. 
IPA network analysis illustrating the top scoring networks identified. A number of pathways that play 
a role in osteoclast differentiation were predicted to be inhibited in the nanokick group. The overall 
picture was similar to that of the CD14+ culture. Potentially significant complexes included JNK, 
NADPH oxidase, IL-1, NF-κB, LDL, C/EBP and HIF1. Osteoblast stimulatory factors were found to 
be increased, including ALP and AMPK. These complexes are indicted by the canonical pathway 
arrows for IL-6 and role of osteoblasts and osteoclasts in rheumatoid arthritis. These pathways were 
chosen given the significant reduction in IL-6 identified in RT-qPCR and ELISA and the relevance of 
osteoblast/osteoclast imbalance to this study. Blue = inhibition, orange = upregulation. CP = 
canonical pathway. N=3 cell donors. 
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Figure 6:4 Metabolomics network and selected pathways for 2D day 21 co-culture. 
IPA network analysis illustrating the top scoring networks identified. There were similar predicted 
trends identified at this time point to both day 14 co-culture and the CD14+ culture. This included 
inhibition of IL-1, NF-κB, LDL, C/EBP, TNF and JNK. Other potentially significant factors that were 
inhibited included Rap1 and ITGAM, both of which are important for osteoclast differentiation and 
function. The potentially significant complexes are indicated by the canonical pathway arrows for IL-
6 and role of osteoblast and osteoclast in rheumatoid arthritis. Blue = inhibition, orange = 
upregulation. CP = canonical pathway. N=3 cell donors. 
 
 
 
 
 
 
Chapter 6 Appendices   146 
 
 
Figure 6:5 Metabolomics network and selected pathways for 3D day 14 co-culture. 
IPA network analysis illustrating the top scoring networks identified. A number of inflammatory and 
osteoclast-stimulatory metabolomes were predicted to be inhibited. This included TNF, JNK, IL-1, 
HIF1, AhR and IFN-ϒ. The osteogenic marker ALP was increased. These complexes are highlighted 
in the overlaid pathways for IL-6 and role of osteoblast and osteoclasts in rheumatoid arthritis. In 
these pathways, all complexes were predicted to be inhibited, except ALP. The overall trends 
identified were comparable with the prior metabolomics experimental conditions. Blue = inhibition, 
orange = upregulation. CP = canonical pathway. N=3 cell donors. 
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Figure 6:6 Metabolomics network and selected pathways for 3D day 21 co-culture.  
IPA network analysis illustrating the top scoring networks identified. Similar to the prior experimental 
conditions, there was a predicted reduction in multiple inflammatory and osteoclast-stimulatory 
complexes, including TNF, IL-1, JNK, C-EBP, EGFR and CXCR2. Conversely, there was an increase 
in HIF1, LDL and NADPH oxidase which has not previously been noted in any other conditions. This 
therefore produces a more conflicting picture. These complexes are indicated by the canonical 
pathway arrows for IL-6 and role of osteoblast and osteoclasts in rheumatoid arthritis. Blue = 
inhibition, orange = upregulation. CP = canonical pathway. N=3 cell donors. 
 
 
